<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T10:52:16Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:6174123" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:6174123</identifier>
        <datestamp>2018-10-15</datestamp>
        <setSpec>physrep</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Physiol Rep</journal-id>
              <journal-id journal-id-type="iso-abbrev">Physiol Rep</journal-id>
              <journal-id journal-id-type="doi">10.1002/(ISSN)2051-817X</journal-id>
              <journal-id journal-id-type="publisher-id">PHY2</journal-id>
              <journal-id journal-id-type="hwp">physreports</journal-id>
              <journal-title-group>
                <journal-title>Physiological Reports</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2051-817X</issn>
              <publisher>
                <publisher-name>John Wiley and Sons Inc.</publisher-name>
                <publisher-loc>Hoboken</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC6174123</article-id>
              <article-id pub-id-type="pmcid">PMC6174123</article-id>
              <article-id pub-id-type="pmc-uid">6174123</article-id>
              <article-id pub-id-type="pmid">30294974</article-id>
              <article-id pub-id-type="doi">10.14814/phy2.13825</article-id>
              <article-id pub-id-type="publisher-id">PHY213825</article-id>
              <article-categories>
                <subj-group subj-group-type="article-subject-classification">
                  <subject>Cardiovascular Conditions, Disorders and Treatments</subject>
                </subj-group>
                <subj-group subj-group-type="article-subject-classification">
                  <subject>Renal Conditions, Disorders and Treatments</subject>
                </subj-group>
                <subj-group subj-group-type="article-subject-classification">
                  <subject>Kidney</subject>
                </subj-group>
                <subj-group subj-group-type="article-subject-classification">
                  <subject>Immunology</subject>
                </subj-group>
                <subj-group subj-group-type="overline">
                  <subject>Original Research</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Original Research</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Exercise during hemodialysis does not affect the phenotype or prothrombotic nature of microparticles but alters their proinflammatory function</article-title>
                <alt-title alt-title-type="left-running-head">N. Martin et al.</alt-title>
              </title-group>
              <contrib-group>
                <contrib id="phy213825-cr-0001" contrib-type="author">
                  <name>
                    <surname>Martin</surname>
                    <given-names>Naomi</given-names>
                  </name>
                  <xref ref-type="aff" rid="phy213825-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="phy213825-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="phy213825-cr-0002" contrib-type="author">
                  <name>
                    <surname>Smith</surname>
                    <given-names>Alice C.</given-names>
                  </name>
                  <xref ref-type="aff" rid="phy213825-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="phy213825-cr-0003" contrib-type="author">
                  <name>
                    <surname>Dungey</surname>
                    <given-names>Maurice R.</given-names>
                  </name>
                  <xref ref-type="aff" rid="phy213825-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="phy213825-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="phy213825-cr-0004" contrib-type="author">
                  <name>
                    <surname>Young</surname>
                    <given-names>Hannah M. L.</given-names>
                  </name>
                  <xref ref-type="aff" rid="phy213825-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="phy213825-cr-0005" contrib-type="author">
                  <name>
                    <surname>Burton</surname>
                    <given-names>James O.</given-names>
                  </name>
                  <xref ref-type="aff" rid="phy213825-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="phy213825-cr-0006" contrib-type="author" corresp="yes">
                  <name>
                    <surname>Bishop</surname>
                    <given-names>Nicolette C.</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6221-3907</contrib-id>
                  <address>
                    <email>n.c.bishop@lboro.ac.uk</email>
                  </address>
                  <xref ref-type="aff" rid="phy213825-aff-0001">
                    <sup>1</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="phy213825-aff-0001">
                <label>
                  <sup>1</sup>
                </label>
                <named-content content-type="organisation-division">National Centre for Sport and Exercise Medicine</named-content>
                <named-content content-type="organisation-division">School of Sport, Exercise and Health Sciences</named-content>
                <institution>Loughborough University</institution>
                <named-content content-type="city">Leicestershire</named-content>
                <country country="GB">United Kingdom</country>
              </aff>
              <aff id="phy213825-aff-0002">
                <label>
                  <sup>2</sup>
                </label>
                <named-content content-type="organisation-division">Leicester Kidney Lifestyle Team</named-content>
                <named-content content-type="organisation-division">Department of Infection, Immunity &amp; Inflammation</named-content>
                <institution>University of Leicester and John Walls Renal Unit</institution>
                <institution>University Hospitals of Leicester NHS Trust</institution>
                <named-content content-type="city">Leicestershire</named-content>
                <country country="GB">United Kingdom</country>
              </aff>
              <author-notes>
                <corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Nicolette C. Bishop, National Centre for Sport and Exercise Medicine, School of Sport, Exercise and Health Sciences, Loughborough University, Leicestershire LE11 3TU, UK.<break/>
Tel: + 44 1509 226385<break/>
E‐mail: <email>n.c.bishop@lboro.ac.uk</email><break/></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>07</day>
                <month>10</month>
                <year>2018</year>
              </pub-date>
              <pub-date pub-type="collection">
                <month>9</month>
                <year>2018</year>
              </pub-date>
              <volume>6</volume>
              <issue>19</issue>
              <issue-id pub-id-type="doi">10.1002/phy2.2018.6.issue-19</issue-id>
              <elocation-id>e13825</elocation-id>
              <history>
                <date date-type="received">
                  <day>12</day>
                  <month>7</month>
                  <year>2018</year>
                </date>
                <date date-type="accepted">
                  <day>19</day>
                  <month>7</month>
                  <year>2018</year>
                </date>
              </history>
              <permissions>
                <!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2018 Published by the American Physiological Society and The Physiological Society <copyright-statement>-->
                <copyright-statement content-type="article-copyright">© 2018 The Authors. <italic>Physiological Reports</italic> published by Wiley Periodicals, Inc. on behalf of The Physiological Society and the American Physiological Society.</copyright-statement>
                <license license-type="creativeCommonsBy">
                  <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:type="simple" xlink:href="file:PHY2-6-e13825.pdf"/>
              <abstract id="phy213825-abs-0001">
                <title>Abstract</title>
                <p>Hemodialysis patients have dysfunctional immune systems, chronic inflammation and comorbidity‐associated risks of cardiovascular disease (<styled-content style="fixed-case">CVD</styled-content>) and infection. Microparticles are biologically active nanovesicles shed from activated endothelial cells, immune cells, and platelets; they are elevated in hemodialysis patients and are associated with chronic inflammation and predictive of <styled-content style="fixed-case">CVD</styled-content> mortality in this group. Exercise is advocated in hemodialysis to improve cardiovascular health yet acute exercise induces an increase in circulating microparticles in healthy populations. Therefore, this study aimed to assess acute effect of intradialytic exercise (<styled-content style="fixed-case">IDE</styled-content>) on microparticle number and phenotype, and their ability to induce endothelial cell reactive oxygen species (<styled-content style="fixed-case">ROS</styled-content>) in vitro. Eleven patients were studied during a routine hemodialysis session and one where they exercised in a randomized cross‐over design. Microparticle number increased during hemodialysis (2064–7071 microparticles/<italic>μ</italic>L, <italic>P</italic> &lt; 0.001) as did phosphatidylserine+ (<italic>P</italic> &lt; 0.05), platelet‐derived (<italic>P</italic> &lt; 0.01) and percentage procoagulant neutrophil‐derived microparticles (<italic>P</italic> &lt; 0.05), but this was not affected by <styled-content style="fixed-case">IDE</styled-content>. However, microparticles collected immediately and 60 min after <styled-content style="fixed-case">IDE</styled-content> (but not later) induced greater <styled-content style="fixed-case">ROS</styled-content> generation from cultured endothelial cells (<italic>P</italic> &lt; 0.05), suggesting a transient proinflammatory event. In summary <styled-content style="fixed-case">IDE</styled-content> does not further increase prothrombotic microparticle numbers that occurs during hemodialysis. However, given acute proinflammatory responses to exercise stimulate an adaptation toward a circulating anti‐inflammatory environment, microparticle‐induced transient increases of endothelial cell <styled-content style="fixed-case">ROS</styled-content> in vitro with <styled-content style="fixed-case">IDE</styled-content> may indicate the potential for a longer‐term anti‐inflammatory adaptive effect. These findings provide a crucial evidence base for future studies of microparticles responses to <styled-content style="fixed-case">IDE</styled-content> in view of the exceptionally high risk of <styled-content style="fixed-case">CVD</styled-content> in these patients.</p>
              </abstract>
              <kwd-group kwd-group-type="author-generated">
                <kwd id="phy213825-kwd-0001">Cardiovascular disease</kwd>
                <kwd id="phy213825-kwd-0002">hemodialysis</kwd>
                <kwd id="phy213825-kwd-0003">inflammation</kwd>
                <kwd id="phy213825-kwd-0004">kidney</kwd>
                <kwd id="phy213825-kwd-0005">microparticles</kwd>
              </kwd-group>
              <funding-group>
                <award-group>
                  <funding-source>Stoneygate Trust</funding-source>
                </award-group>
                <award-group>
                  <funding-source>National Institute for Health Research (NIHR) Leicester Biomedical Research Centre</funding-source>
                </award-group>
              </funding-group>
              <counts>
                <fig-count count="5"/>
                <table-count count="3"/>
                <page-count count="13"/>
                <word-count count="8370"/>
              </counts>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>source-schema-version-number</meta-name>
                  <meta-value>2.0</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>component-id</meta-name>
                  <meta-value>phy213825</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>cover-date</meta-name>
                  <meta-value>September 2018</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>details-of-publishers-convertor</meta-name>
                  <meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.5.0 mode:remove_FC converted:07.10.2018</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <p content-type="self-citation">
                <mixed-citation publication-type="journal" id="phy213825-cit-1001"><string-name><given-names>N.</given-names><surname>Martin</surname></string-name>, <string-name><given-names>A. C.</given-names><surname>Smith</surname></string-name>, <string-name><given-names>M. R.</given-names><surname>Dungey</surname></string-name>, <string-name><given-names>H. M. L.</given-names><surname>Young</surname></string-name>, <string-name><given-names>J. O.</given-names><surname>Burton</surname></string-name>, <string-name><given-names>N. C.</given-names><surname>Bishop</surname></string-name>. <article-title>Exercise during hemodialysis does not affect the phenotype or prothrombotic nature of microparticles but alters their proinflammatory function</article-title>. <source xml:lang="en">Physiol Rep</source>, <volume>6</volume> (<issue>19</issue>), <year>2018</year>, <elocation-id>e13825</elocation-id>, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.14814/phy2.13825">https://doi.org/10.14814/phy2.13825</ext-link>
</mixed-citation>
              </p>
              <fn-group id="phy213825-ntgp-0001">
                <fn fn-type="funding" id="phy213825-note-1001">
                  <p>
                    <bold>Funding Information</bold>
                  </p>
                  <p>The research was supported by the Stoneygate Trust and the National Institute for Health Research (NIHR) Leicester Biomedical Research Centre.</p>
                </fn>
              </fn-group>
            </notes>
          </front>
          <body>
            <sec id="phy213825-sec-0001">
              <title>Introduction</title>
              <p>Chronic kidney disease (CKD) affects approximately 10% of the world's population (Eckardt et al. <xref rid="phy213825-bib-0025" ref-type="ref">2013</xref>). Patients with end‐stage renal disease have a dysfunctional immune system that is paradoxically chronically activated and anergic (Betjes <xref rid="phy213825-bib-0009" ref-type="ref">2013</xref>); this manifests as systemic inflammation associated with an increased risk of atherosclerosis, cardiovascular disease (CVD), and cachexia (Stenvinkel <xref rid="phy213825-bib-0065" ref-type="ref">2010</xref>; Heine et al. <xref rid="phy213825-bib-0036" ref-type="ref">2012</xref>). End‐stage renal disease patients are also immunologically vulnerable (Kurts et al. <xref rid="phy213825-bib-0045" ref-type="ref">2013</xref>) and have higher risk and greater severity of infections and associated tissue injury (Dalrymple and Go <xref rid="phy213825-bib-0020" ref-type="ref">2008</xref>). As such, the progression of CKD is in part mediated by the immune system (Kurts et al. <xref rid="phy213825-bib-0045" ref-type="ref">2013</xref>). Hemodialysis (HD) itself is associated with further increased mortality, aggravated by cardiac injury induced by intradialytic hypotension (Shoji et al. <xref rid="phy213825-bib-0063" ref-type="ref">2004</xref>), myocardial stunning (Burton et al. <xref rid="phy213825-bib-0013" ref-type="ref">2009</xref>), immune activation aggravated by endotoxin influx (Kurts et al. <xref rid="phy213825-bib-0045" ref-type="ref">2013</xref>) and biomaterial‐induced complement activation (Nilsson et al. <xref rid="phy213825-bib-0052" ref-type="ref">2007</xref>).</p>
              <p>Patients with kidney disease have an altered immune and inflammatory profile, possibly due to the uremic environment (Girndt et al. <xref rid="phy213825-bib-0033" ref-type="ref">2001</xref>), with increased proinflammatory T‐cells, monocytes, monocyte and neutrophil Toll‐Like Receptor 4 activity and activated platelet aggregates (Ashman et al. <xref rid="phy213825-bib-0004" ref-type="ref">2003</xref>; Gollapudi et al. <xref rid="phy213825-bib-0035" ref-type="ref">2010</xref>; Kurts et al. <xref rid="phy213825-bib-0045" ref-type="ref">2013</xref>). This is associated with elevated concentrations of circulating proinflammatory cytokines including TNF<italic>α</italic>, IL‐6 and the acute phase reactant, C‐reactive protein (Girndt et al. <xref rid="phy213825-bib-0032" ref-type="ref">1995</xref>; Costa et al. <xref rid="phy213825-bib-0018" ref-type="ref">2008</xref>). Chronic inflammation increases incrementally with CKD progression (Kaysen <xref rid="phy213825-bib-0043" ref-type="ref">2014</xref>) and is intrinsically linked to the high risk of mortality and morbidity from CVD in these patients (Stenvinkel <xref rid="phy213825-bib-0065" ref-type="ref">2010</xref>). In CKD, microparticles (MP) have proinflammatory actions (Puddu et al. <xref rid="phy213825-bib-0057" ref-type="ref">2010</xref>) and have been associated with endothelial damage, increased risk for calcification, anemia, and thrombosis (Gao et al. <xref rid="phy213825-bib-0031" ref-type="ref">2015</xref>; Erdbrügger and Li <xref rid="phy213825-bib-0027" ref-type="ref">2016</xref>), with endothelial derived MP collected 72 h after last dialysis reported to independently predict all‐cause and CVD mortality in stable HD patients (Amabile et al. <xref rid="phy213825-bib-0002" ref-type="ref">2012</xref>). MP are shed from activated or apoptotic sources including immune cells platelets and endothelial cells (Boulanger et al. <xref rid="phy213825-bib-0012" ref-type="ref">2007</xref>), with their actions depending on their cellular origin (Barteneva et al. <xref rid="phy213825-bib-0008" ref-type="ref">2013</xref>). These intact circulating membrane nanovesicles range in size from 100 to 1000 nm and are composed of plasma membrane and the cytoplasmic contents of their parent cell (Morel et al. <xref rid="phy213825-bib-0050" ref-type="ref">2011</xref>). MP act as systemic signaling vehicles and their inflammatory actions include inducing leukocyte aggregation (Forlow et al. <xref rid="phy213825-bib-0029" ref-type="ref">2000</xref>), chemotaxis (Barry et al. <xref rid="phy213825-bib-0007" ref-type="ref">1998</xref>) and the release of cytokines (Puddu et al. <xref rid="phy213825-bib-0057" ref-type="ref">2010</xref>). Indeed, MP can transport and transfer proteins such as tissue factor, a major initiator of blood coagulation, contributing to endothelial dysfunction (Scholz et al. <xref rid="phy213825-bib-0062" ref-type="ref">2002</xref>). The actions of MP therefore represent a connection between chronic inflammation and CVD in CKD.</p>
              <p>Lower levels of physical activity are a risk factor for CVD yet within the HD population patients are frequently inactive (Johansen et al. <xref rid="phy213825-bib-0041" ref-type="ref">2000</xref>) and this is associated with a risk mortality of similar magnitude to that of other well‐established risk factors, such as a one‐point reduction in serum albumin concentration (O'Hare et al. <xref rid="phy213825-bib-0053" ref-type="ref">2003</xref>). A recent Cochrane review reported a plethora of benefits of regular exercise for this population, including improvements to cardiovascular health (Heiwe and Jacobson <xref rid="phy213825-bib-0037" ref-type="ref">2014</xref>). The so‐called “anti‐inflammatory” effect of regular exercise is thought to play a key role through various different mechanisms that centre on a chronic adaptive response to repeated transient proinflammatory events during and following acute exercise sessions (Gleeson et al. <xref rid="phy213825-bib-0034" ref-type="ref">2011</xref>). These include reducing visceral adipose tissue mass and associated inflammatory cytokine release, stimulating transient acute proinflammatory cytokine release from muscle, leading to a counteractive, longer lasting release of anti‐inflammatory mediators and movement from a proinflammatory toward an anti‐inflammatory profile of immune cell phenotypes (Gleeson et al. <xref rid="phy213825-bib-0034" ref-type="ref">2011</xref>). Indeed, we have recently reported favorable changes in inflammatory leukocyte phenotype with a reduction in monocytes with a proinflammatory phenotype in patients after 6 months of moderate intensity IDE compared with non‐exercising HD patients (Dungey et al. <xref rid="phy213825-bib-0023" ref-type="ref">2017</xref>). This is arguably as an adaptive response to regular exercise given our earlier observation of acute elevations in proinflammatory monocyte phenotypes in response to a single IDE session of the same intensity (Dungey et al. <xref rid="phy213825-bib-0022" ref-type="ref">2015</xref>). Acute exercise is also known to induce an increase in circulating MP (Frühbeis et al. <xref rid="phy213825-bib-0030" ref-type="ref">2015</xref>) and in healthy populations, transient increases in, platelet‐, monocyte‐, and EC‐derived MP (Lansford et al. <xref rid="phy213825-bib-0047" ref-type="ref">2016</xref>) have been reported following acute moderate‐vigorous exercise. These acute elevations are thought to be necessary to stimulate an anti‐inflammatory adaptation with repeated exercise sessions as lower numbers of EC MP are reported in healthy individuals in response to long‐term aerobic training (Kim et al. <xref rid="phy213825-bib-0044" ref-type="ref">2015</xref>). Therefore, the aim of this study was to assess the acute effect of IDE on the total number, cellular origin, prothrombotic phenotype and ROS inducing ability of circulating MP. We hypothesized that an acute bout of IDE would induce a greater MP response compared to routine HD.</p>
            </sec>
            <sec id="phy213825-sec-0002">
              <title>Materials and Methods</title>
              <p>This novel investigation used samples collected from a subgroup of patients recruited to our previously published study (Dungey et al. <xref rid="phy213825-bib-0022" ref-type="ref">2015</xref>). While the trial protocol is the same, the analyses and data presented here are novel and have not been previously published.</p>
              <sec id="phy213825-sec-0003">
                <title>Patients</title>
                <p>Eleven patients were recruited from a satellite unit of University Hospitals of Leicester NHS Trust. In this randomized crossover study, patients were studied during a routine HD session and also one where they completed exercise. Exclusion criteria were: age &lt; 18 years, lower limb vascular access, cardiovascular event in the last 3 months, severe heart failure, severe chronic obstructive pulmonary disease, acute liver disease, uncontrolled diabetes mellitus, severe lower limb orthopedic problems, severe lower limb neuromuscular disease, clinically overt infection in the last 6 weeks, pregnancy, insufficient command of English to understand the patient information sheet and give informed consent. All patients had one or more significant non‐renal comorbidity reported in their medical history. Specifically, 2 of the 11 patients had diabetes mellitus (18%), 9 were diagnosed with hypertension (81%), and 5 were diagnosed with heart disease (54%). All patients used polysulfone high‐flux dialyzers. The dialysate, dialyzer, needle size and dialysis duration and prescriptions were unchanged between study days. The study received approval from the NHS Research Ethics Committee (ref. 10/H0406/36), and all patients gave written informed consent to participate. Patient characteristics are represented in Table <xref rid="phy213825-tbl-0001" ref-type="table">1</xref>.</p>
                <table-wrap id="phy213825-tbl-0001" xml:lang="en" orientation="portrait" position="float">
                  <label>Table 1</label>
                  <caption>
                    <p>Patients' characteristics</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Age (y)</td>
                        <td align="left" rowspan="1" colspan="1">59 ± 10</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="2" rowspan="1">Sex (<italic>n</italic>)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Male/Female</td>
                        <td align="left" rowspan="1" colspan="1">7/4</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="2" rowspan="1">Ethnicity (<italic>n</italic>)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">White British</td>
                        <td align="left" rowspan="1" colspan="1">4 (36%)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Indian</td>
                        <td align="left" rowspan="1" colspan="1">7 (64%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Height (cm)</td>
                        <td align="left" rowspan="1" colspan="1">166 ± 9</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Dry weight (kg)</td>
                        <td align="left" rowspan="1" colspan="1">80.2 ± 19.2</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td>
                        <td align="left" rowspan="1" colspan="1">28.8 ± 6.8</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Hemodialysis vintage (y)</td>
                        <td align="left" rowspan="1" colspan="1">3.62 (0.94–3.82)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="2" rowspan="1">Access</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">AVF</td>
                        <td align="left" rowspan="1" colspan="1">9 (82%)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Catheter</td>
                        <td align="left" rowspan="1" colspan="1">2 (12%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="6" colspan="1">Primary disease (<italic>n</italic>)</td>
                        <td align="left" rowspan="1" colspan="1">Glomerulonephritis (3)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Cystic/Poly (2)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Diabetes (1)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Pyelonephritis (1)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Uncertain (3)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Other (1)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Number of co‐morbidities</td>
                        <td align="left" rowspan="1" colspan="1">4 ± 2 (range 1–7)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Number of medications</td>
                        <td align="left" rowspan="1" colspan="1">12 ± 4 (range 4–16)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"><xref ref-type="fn" rid="phy213825-note-0100">a</xref>Systolic blood pressure (mmHg)</td>
                        <td align="left" rowspan="1" colspan="1">122 (111–145)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"><xref ref-type="fn" rid="phy213825-note-0100">a</xref>Diastolic blood pressure (mmHg)</td>
                        <td align="left" rowspan="1" colspan="1">64 (56–71)</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="phy213825-note-0002">
                      <p>Data are mean ± standard deviation, median (interquartile range), or <italic>n</italic> (%).</p>
                    </fn>
                    <fn id="phy213825-note-0100">
                      <label>a</label>
                      <p>Blood pressure variables are based on a 3‐day average taken before (and not including) the first trial day.</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
                  </permissions>
                </table-wrap>
              </sec>
              <sec id="phy213825-sec-0004">
                <title>Exercise session</title>
                <p>The exercise session has been described in detail previously (Dungey et al. <xref rid="phy213825-bib-0022" ref-type="ref">2015</xref>). Briefly, patients participated in 2 trial arms, separated by a week and carried out on the same day each week. For the exercise arm, 60 min into their HD treatment patients performed a 5 min warm‐up followed by a 30 min bout of IDE using a specially designed cycle ergometer (Letto series; Reck, Germany). Patients cycled at self‐selected gears at a rating of perceived exertion of “somewhat hard” (Borg <xref rid="phy213825-bib-0010" ref-type="ref">1973</xref>). Patients routinely took part in an exercise program for at least 3 months prior to this study therefore the study here represents the usual effects of regular IDE for these patients. During the control non‐exercising arm of the study patients rested throughout HD.</p>
              </sec>
              <sec id="phy213825-sec-0005">
                <title>Phlebotomy and microparticle isolation</title>
                <p>To investigate the acute effects of exercise, blood samples were taken from the HD lines pre‐exercise (60 min of HD), immediately after exercise (post‐exercise, 100 min of HD), 1 h post‐exercise (160 min of HD, and at the end of HD (240 min of HD). In the non‐exercising control sessions bloods were taken at equivalent times of HD. Blood was drawn using a dry syringe and immediately aliquoted into a trisodium citrate pretreated monovette (Sarstedt AG, Nümbrecht, Germany). Platelet‐poor plasma was prepared from blood samples following two centrifugation steps of 2500<italic>g</italic> for 20 min at 4°C, and then stored in 250 <italic>μ</italic>L aliquots at −80°C until use. MP in cell‐free plasma were prepared according to Jy et al. (<xref rid="phy213825-bib-0042" ref-type="ref">2004</xref>).</p>
              </sec>
              <sec id="phy213825-sec-0006">
                <title>Flow cytometry</title>
                <p>Annexin V (AnV) expression was used to detect phosphatidylserine expression on MP, considered to be prothrombotic (Owens and Mackman <xref rid="phy213825-bib-0054" ref-type="ref">2011</xref>). Aliquots of MP were incubated alone, with Annexin V‐fluorescein isothiocyanate (AnV‐FITC) (BD Biosciences, Oxford, UK) as a marker of phosphatidylserine expression, and buffer A (10 mmol/L HEPES, 140 mmol/L NaCl, 2.5 mmol/L CaCl<sub>2</sub>, pH 7.4) or with AnV‐FITC and a calcium‐free control buffer B (10 mmol/L HEPES, 140 mmol/L NaCl, pH 7.4) in the dark for 25 min at RT. Buffer A was added to MP alone, or AnV‐stained MP, while control AnV staining was assessed with by adding buffer B to AnV‐stained MP. Phenotypic labeling was performed with the following mouse anti‐human phycoerythrin(PE)‐labeled antibodies to specific cell surface markers: platelet CD42b, endothelial cell CD144, tissue factor CD142, neutrophil CD66b, monocyte CD14, or appropriate isotype control antibodies (all BD Biosciences, Oxford, UK). MP were also dual‐labeled with phenotyping antibodies as above plus AnV‐FITC. All antibody incubations were carried out as described above and MP were resuspended in buffer A. MP were enumerated using Flow‐Count Fluorospheres™ (Beckman Coulter, High Wycombe, UK). All flow cytometric acquisition was done using a FACSCanto II and all analysis was carried out using FACSDiva™ software (both BD Biosciences, Oxford, UK). MP were acquired using a gating defined by size‐calibrated fluorescent Megamix™ beads according to the manufacturer's instructions (BioCytex, Marseille, France) and according to a standardized calibrated‐bead strategy (Robert et al. <xref rid="phy213825-bib-0060" ref-type="ref">2008</xref>). Examples of flow cytometric profiles are shown in Figure <xref rid="phy213825-fig-0001" ref-type="fig">1</xref>. All samples were acquired using the slowest flow rate for a fixed time period of 120 seconds.</p>
                <fig fig-type="Figure" xml:lang="en" id="phy213825-fig-0001" orientation="portrait" position="float">
                  <label>Figure 1</label>
                  <caption>
                    <p>Examples of flow cytometric analysis of microparticles. Representative graphs from cytofluorometric analysis of <styled-content style="fixed-case">MP</styled-content> in platelet‐free plasma from non‐exercising <styled-content style="fixed-case">CKD</styled-content> patient undergoing <styled-content style="fixed-case">HD</styled-content>. (A) Construction of <styled-content style="fixed-case">MP</styled-content> gating region using Megamix submicrometer beads (based on (Puddu et al. <xref rid="phy213825-bib-0057" ref-type="ref">2010</xref>)) and <styled-content style="fixed-case">MP</styled-content> enumeration using Flow‐Count beads. (B) Determination of phosphatidylserine/AnnexinV<sup>+</sup>
<styled-content style="fixed-case">MP</styled-content>. Representative phenotyping flow cytometric analysis of <styled-content style="fixed-case">MP</styled-content>, comparing positively stained gated <styled-content style="fixed-case">MP</styled-content> were determined by comparison with isotype control staining (C). <styled-content style="fixed-case">CD</styled-content>42b<sup>+</sup> (platelet‐derived) <styled-content style="fixed-case">MP</styled-content> events from samples taken 60 min into <styled-content style="fixed-case">HD</styled-content> (D) to those the end of the <styled-content style="fixed-case">HD</styled-content> session (E).</p>
                  </caption>
                  <graphic id="nlm-graphic-3" xlink:href="PHY2-6-e13825-g001"/>
                </fig>
              </sec>
              <sec id="phy213825-sec-0007">
                <title>MP‐induced reactive oxygen species generation</title>
                <p>EA.hy926 EC lines were maintained according to the manufacturer's instructions; they were cultured in DMEM supplemented with 10% (v/v) heat‐inactivated fetal calf serum, 2 mmol/L <sc>l</sc>‐glutamine, 100 U/mL penicillin, 100 <italic>μ</italic>g/mL streptomycin (all Life Technologies, Warrington, UK) and maintained at 37°C in a humidified 5% CO<sub>2</sub> atmosphere. EA.hy926 cells were seeded onto black 96‐well plates (Perkin Elmer, Seer Green, UK) at a density of 2.5 × 10<sup>4</sup> cells/well. The following day the medium was removed and cells were loaded with 5 <italic>μ</italic>mol/L dichloro‐dihydro‐fluorescein diacetate (DCFH‐DA) (Sigma, Gillingham, UK) at a final concentration of 10 <italic>μ</italic>g/mL in medium for 15 min at 37°C in the dark before the addition of 25 <italic>μ</italic>L MP (prepared and enumerated as above), control buffers or medium (Sigma, Gillingham, UK). Fluorescence was measured at 529 nm immediately, every 15 min for 2 h at 37°C and finally after a 20 h incubation at 37°C in a humidified 5% CO<sub>2</sub> atmosphere, using a Varioskan™ Flash Multimode Reader (Thermo Fisher Scientific, Loughborough, UK). Each treatment was carried out in duplicate.</p>
              </sec>
              <sec id="phy213825-sec-0008">
                <title>Statistics</title>
                <p>Treatment conditions and baseline differences between arms were compared using paired <italic>t</italic>‐tests or Wilcoxon signed‐ranks tests where applicable. Two‐factor repeated measures ANOVA was used to analyze data: trial arm (exercise vs. control) × time. Where data were non‐normally distributed (Shapiro‐Wilk) ANOVA was performed on the logarithmic transformation of the data and reported in original form. If the omnibus test found a significant effect post hoc paired <italic>t</italic>‐tests and repeated contrasts were used and adjusted for multiple comparisons using the Holm‐Bonferroni method (Holm <xref rid="phy213825-bib-0038" ref-type="ref">1979</xref>). Statistical analysis was performed on Statistical Package for Social Sciences (SPSS v.22, IBM, New York). Data are presented as mean ± standard deviation or median (interquartile range) as described. Statistical significance was accepted at <italic>P</italic> &lt; 0.05.</p>
              </sec>
            </sec>
            <sec id="phy213825-sec-0009">
              <title>Results</title>
              <sec id="phy213825-sec-0010">
                <title>Exercise and hemodialysis</title>
                <p>All 11 recruited patients successfully completed 30 min of cycling starting 60 min into HD on the exercise trial. The mean power output was measured as 22.5 ± 7.3 W. Pre HD body mass, ultrafiltration goal and pump speed did not differ between exercise and resting trials (Table <xref rid="phy213825-tbl-0002" ref-type="table">2</xref>). No adverse events were reported.</p>
                <table-wrap id="phy213825-tbl-0002" xml:lang="en" orientation="portrait" position="float">
                  <label>Table 2</label>
                  <caption>
                    <p>Hemodialysis treatment variables on exercise and control trial arms</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <thead valign="top">
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" valign="top" rowspan="1" colspan="1"/>
                        <th align="center" valign="top" rowspan="1" colspan="1">Exercise</th>
                        <th align="center" valign="top" rowspan="1" colspan="1">Control</th>
                        <th align="center" valign="top" rowspan="1" colspan="1"><italic>P</italic> value</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Pre‐HD weight (kg)</td>
                        <td align="char" char="±" rowspan="1" colspan="1">81.4 ± 19.2</td>
                        <td align="char" char="±" rowspan="1" colspan="1">81.5 ± 19.5</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.736</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Ultrafiltration goal (L)</td>
                        <td align="char" char="±" rowspan="1" colspan="1">1.62 ± 0.63</td>
                        <td align="char" char="±" rowspan="1" colspan="1">1.56 ± 0.74</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.545</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Pump speed (mL/min)</td>
                        <td align="char" char="±" rowspan="1" colspan="1">324 ± 45</td>
                        <td align="char" char="±" rowspan="1" colspan="1">324 ± 45</td>
                        <td align="char" char="." rowspan="1" colspan="1">1.000</td>
                      </tr>
                    </tbody>
                  </table>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
                  </permissions>
                </table-wrap>
              </sec>
              <sec id="phy213825-sec-0011">
                <title>Evaluation of the effects of hemodialysis and IDE on total and prothrombotic microparticles</title>
                <p>We observed a significant increase in the number of MP over the course of HD (main effect of HD, <italic>P</italic> &lt; 0.001) (Fig. <xref rid="phy213825-fig-0002" ref-type="fig">2</xref>) with a ~4 fold increase from 60 min into HD compared to the end of HD. There was no effect of IDE. The overall number (Fig. <xref rid="phy213825-fig-0003" ref-type="fig">3</xref>A), but not % (Fig. <xref rid="phy213825-fig-0003" ref-type="fig">3</xref>B), of MP expressing phosphatidylserine increased significantly over the course of HD (main effect of HD, <italic>P</italic> &lt; 0.05), with increases seen in 22 out of the 26 HD sessions observed. Over the same time there was a decrease (<italic>P </italic>=<italic> </italic>0.066) in % (but not number) of circulating MP expressing tissue factor (Fig. <xref rid="phy213825-fig-0003" ref-type="fig">3</xref>C). Again IDE had no effect on these responses.</p>
                <fig fig-type="Figure" xml:lang="en" id="phy213825-fig-0002" orientation="portrait" position="float">
                  <label>Figure 2</label>
                  <caption>
                    <p>Total numbers of microparticles over the course of <styled-content style="fixed-case">HD</styled-content> in exercising and non‐exercising <styled-content style="fixed-case">CKD</styled-content> patients. Patients on <styled-content style="fixed-case">HD</styled-content> rested (open symbols) or exercised (closed symbols). <styled-content style="fixed-case">MP</styled-content> were isolated, then analyzed and enumerated using flow cytometry, from samples taken 60 min into <styled-content style="fixed-case">HD</styled-content>, immediately following exercise (or equivalent time in control group), 60 min after exercise (equivalent to 160 min into dialysis for control group) and at the end of <styled-content style="fixed-case">HD</styled-content>. Total numbers of <styled-content style="fixed-case">MP</styled-content> had increased significantly by the end of <styled-content style="fixed-case">HD</styled-content> compared to both 60 min and 100 min (main effect for <styled-content style="fixed-case">HD</styled-content>, **<italic>P</italic> &lt; 0.01 for both) into <styled-content style="fixed-case">HD</styled-content>. The numbers of <styled-content style="fixed-case">MP</styled-content> at 160 min into <styled-content style="fixed-case">HD</styled-content> were also significantly greater than those observed 60 min into <styled-content style="fixed-case">HD</styled-content> (*<italic>P</italic> &lt; 0.05). All of these observed increases were irrespective of <styled-content style="fixed-case">IDE</styled-content>. All <italic>n</italic> = 10.</p>
                  </caption>
                  <graphic id="nlm-graphic-5" xlink:href="PHY2-6-e13825-g002"/>
                </fig>
                <fig fig-type="Figure" xml:lang="en" id="phy213825-fig-0003" orientation="portrait" position="float">
                  <label>Figure 3</label>
                  <caption>
                    <p>Procoagulant microparticles over the course of <styled-content style="fixed-case">HD</styled-content> in exercising and non‐exercising <styled-content style="fixed-case">CKD</styled-content> patients. Patients on <styled-content style="fixed-case">HD</styled-content> rested (open symbols) or exercised (closed symbols). <styled-content style="fixed-case">MP</styled-content> isolated from samples were taken 60 min into <styled-content style="fixed-case">HD</styled-content>, immediately following exercise (or equivalent time in control group), 60 min after exercise (equivalent to 160 min into dialysis for control group) and at the end of <styled-content style="fixed-case">HD</styled-content> were labeled with AnnexinV which binds to phosphatidylserine, or anti‐<styled-content style="fixed-case">CD</styled-content>142, and analyzed using flow cytometry. There was a significant increase in the number of phosphatidylserine‐positive <styled-content style="fixed-case">MP</styled-content> (A) in both groups from 60 min into <styled-content style="fixed-case">HD</styled-content> compared to at the end of <styled-content style="fixed-case">HD</styled-content> (main effect of <styled-content style="fixed-case">HD</styled-content>, *<italic>P</italic> &lt; 0.05), but there was no significant change in the percentage of <styled-content style="fixed-case">MP</styled-content> stained with AnV (B) over the course of <styled-content style="fixed-case">HD</styled-content> or any differences between exercising or non‐exercising groups. Number of <styled-content style="fixed-case">CD</styled-content>142<sup>+</sup> tissue factor expressing <styled-content style="fixed-case">MP</styled-content> were unaffected by <styled-content style="fixed-case">HD</styled-content> or <styled-content style="fixed-case">IDE</styled-content> (data not shown) yet there was a significant decrease in the percentage of <styled-content style="fixed-case">CD</styled-content>142<sup>+</sup>
<styled-content style="fixed-case">MP</styled-content> (C) between 100 and 160 min of <styled-content style="fixed-case">HD</styled-content> (main effect for <styled-content style="fixed-case">HD</styled-content>, *<italic>P</italic> &lt; 0.05), irrespective of exercise. All <italic>n</italic> = 11.</p>
                  </caption>
                  <graphic id="nlm-graphic-7" xlink:href="PHY2-6-e13825-g003"/>
                </fig>
              </sec>
              <sec id="phy213825-sec-0012">
                <title>Evaluation of the effects of hemodialysis and IDE on the cellular origin of microparticles</title>
                <p>There was a significant increase in the number of platelet‐derived CD42b+MP by the end of HD (main effect of HD, <italic>P</italic> &lt; 0.001, Table <xref rid="phy213825-tbl-0003" ref-type="table">3</xref>). There were no other significant changes in the numbers of MP derived from the other cellular origins studied, but there was a trend (main effect of HD, <italic>P </italic>=<italic> </italic>0.08) for an increase in monocyte‐derived CD14 + MP over the course of HD (Table <xref rid="phy213825-tbl-0003" ref-type="table">3</xref>). IDE had no effect on these responses. The % procoagulant phosphatidylserine+ MP derived from platelets (Fig. <xref rid="phy213825-fig-0004" ref-type="fig">4</xref>A), EC (data not shown) and monocytes (Fig. <xref rid="phy213825-fig-0004" ref-type="fig">4</xref>B) were unaffected by HD or exercise. However, % neutrophil‐derived phosphatidylserine+CD66b+MP decreased between 100 and 160 min of HD (43.3 ± 28.4% to 24.2 ± 25.4%), main effect of HD, <italic>P</italic> &lt; 0.05; Fig. <xref rid="phy213825-fig-0004" ref-type="fig">4</xref>C). Again IDE had no effect on this response.</p>
                <table-wrap id="phy213825-tbl-0003" xml:lang="en" orientation="portrait" position="float">
                  <label>Table 3</label>
                  <caption>
                    <p>Effects of hemodialysis and intradialytic exercise on numbers of circulating microparticles derived from platelets, endothelial cells, neutrophils, and monocytes</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <thead valign="top">
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" valign="top" rowspan="1" colspan="1">MP phenotype (MP/<italic>μ</italic>L)</th>
                        <th align="center" valign="top" rowspan="1" colspan="1">60 min of HD pre‐ex</th>
                        <th align="center" valign="top" rowspan="1" colspan="1">100 min into HD post‐ex</th>
                        <th align="center" valign="top" rowspan="1" colspan="1">160 min into HD 60 min post‐ex</th>
                        <th align="center" valign="top" rowspan="1" colspan="1">End of HD</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" colspan="5" rowspan="1">Platelet<xref ref-type="fn" rid="phy213825-note-0005">a</xref>
</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Rest</td>
                        <td align="char" char="±" rowspan="1" colspan="1">8.82 ± 7.12</td>
                        <td align="char" char="±" rowspan="1" colspan="1">20.2 ± 17.0</td>
                        <td align="char" char="±" rowspan="1" colspan="1">15.6 ± 15.8</td>
                        <td align="char" char="±" rowspan="1" colspan="1">30.3 ± 18.2</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Exercise</td>
                        <td align="char" char="±" rowspan="1" colspan="1">11.0 ± 7.40</td>
                        <td align="char" char="±" rowspan="1" colspan="1">19.2 ± 21.4</td>
                        <td align="char" char="±" rowspan="1" colspan="1">15.6 ± 13.8</td>
                        <td align="char" char="±" rowspan="1" colspan="1">27.8 ± 31.5</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="5" rowspan="1">Endothelial cell</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Rest</td>
                        <td align="char" char="±" rowspan="1" colspan="1">0.21 ± 0.44</td>
                        <td align="char" char="±" rowspan="1" colspan="1">0.30 ± 0.30</td>
                        <td align="char" char="±" rowspan="1" colspan="1">0.08 ± 0.16</td>
                        <td align="char" char="±" rowspan="1" colspan="1">0.16 ± 0.54</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Exercise</td>
                        <td align="char" char="±" rowspan="1" colspan="1">0.20 ± 0.40</td>
                        <td align="char" char="±" rowspan="1" colspan="1">0.08 ± 0.28</td>
                        <td align="char" char="±" rowspan="1" colspan="1">0.25 ± 0.57</td>
                        <td align="char" char="±" rowspan="1" colspan="1">0.00 ± 0.00</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="5" rowspan="1">Neutrophil</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Rest</td>
                        <td align="char" char="±" rowspan="1" colspan="1">6.51 ± 8.52</td>
                        <td align="char" char="±" rowspan="1" colspan="1">6.74 ± 5.40</td>
                        <td align="char" char="±" rowspan="1" colspan="1">6.25 ± 7.15</td>
                        <td align="char" char="±" rowspan="1" colspan="1">7.18 ± 6.04</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Exercise</td>
                        <td align="char" char="±" rowspan="1" colspan="1">2.84 ± 3.22</td>
                        <td align="char" char="±" rowspan="1" colspan="1">6.09 ± 6.53</td>
                        <td align="char" char="±" rowspan="1" colspan="1">3.57 ± 4.42</td>
                        <td align="char" char="±" rowspan="1" colspan="1">5.93 ± 7.37</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="5" rowspan="1">Monocyte</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Rest</td>
                        <td align="char" char="±" rowspan="1" colspan="1">4.05 ± 5.23</td>
                        <td align="char" char="±" rowspan="1" colspan="1">7.71 ± 10.38</td>
                        <td align="char" char="±" rowspan="1" colspan="1">4.54 ± 2.62</td>
                        <td align="char" char="±" rowspan="1" colspan="1">12.62 ± 11.51</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Exercise</td>
                        <td align="char" char="±" rowspan="1" colspan="1">4.08 ± 4.20</td>
                        <td align="char" char="±" rowspan="1" colspan="1">5.58 ± 3.93</td>
                        <td align="char" char="±" rowspan="1" colspan="1">5.11 ± 4.18</td>
                        <td align="char" char="±" rowspan="1" colspan="1">5.18 ± 3.03</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="phy213825-note-0004">
                      <p>All data are expressed as mean ± SD MP/<italic>μ</italic>L, from 11 patients studied.</p>
                    </fn>
                    <fn id="phy213825-note-0005">
                      <label>a</label>
                      <p><italic>P</italic> &lt; 0.001 platelet‐derived CD42b+MP 60 min into HD versus end of HD; (main effect of HD only).</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
                  </permissions>
                </table-wrap>
                <fig fig-type="Figure" xml:lang="en" id="phy213825-fig-0004" orientation="portrait" position="float">
                  <label>Figure 4</label>
                  <caption>
                    <p>Procoagulant phenotypic microparticles over the course of <styled-content style="fixed-case">HD</styled-content> in exercising and non‐exercising <styled-content style="fixed-case">CKD</styled-content> patients. Patients on <styled-content style="fixed-case">HD</styled-content> rested (open symbols) or exercised (closed symbols). <styled-content style="fixed-case">MP</styled-content> isolated from platelet‐free plasma samples were taken 60 min into <styled-content style="fixed-case">HD</styled-content>, immediately following exercise (or equivalent time in control group), 60 min after exercise (equivalent to 160 min into dialysis for control group) and at the end of <styled-content style="fixed-case">HD</styled-content> and stained with AnnexinV‐<styled-content style="fixed-case">FITC</styled-content> and <styled-content style="fixed-case">PE</styled-content>‐conjugated phenotyping antibodies to determine presence of phosphatidylserine (<styled-content style="fixed-case">PS</styled-content>) and cellular origin, and analyzed using flow cytometry. Procoagulant <styled-content style="fixed-case">PS</styled-content> +  <styled-content style="fixed-case">MP</styled-content> derived from platelets (<styled-content style="fixed-case">CD</styled-content>42b+) (A) and monocytes (<styled-content style="fixed-case">CD</styled-content>14 + ) (B) were unaffected by <styled-content style="fixed-case">HD</styled-content> or <styled-content style="fixed-case">IDE</styled-content>. The % <styled-content style="fixed-case">PS</styled-content>+ neutrophil‐derived <styled-content style="fixed-case">MP</styled-content> (C) decreased 1.8‐fold between 100 min (triangles; 43.3 ± 28.4%) and 160 min into <styled-content style="fixed-case">HD</styled-content> (squares; 24.2 ± 25.4%) (*<italic>P</italic> &lt; 0.05). <styled-content style="fixed-case">IDE</styled-content> had no effect on these responses. All <italic>n</italic> = 11.</p>
                  </caption>
                  <graphic id="nlm-graphic-9" xlink:href="PHY2-6-e13825-g004"/>
                </fig>
              </sec>
              <sec id="phy213825-sec-0013">
                <title>Evaluation of ROS‐inducing effects of microparticles from dialyzing and intradialytic exercising patients</title>
                <p>The ROS‐inducing capabilities of MP taken from patients while exercising and at rest during HD were investigated to provide insight into their function and potential involvement in pathophysiology. MP collected from exercising patients immediately after their IDE session (Fig. <xref rid="phy213825-fig-0005" ref-type="fig">5</xref>A) had significantly greater ability to induce ROS after 120 min incubation with EC compared to MP collected at the same time (100 min into HD) when resting (delta change of 2.82 ± 3.03 compared to −1.68 ± 5.42 DCFHDA fluorescence units per 1000 MP; <italic>P</italic> &lt; 0.05). This increased ROS induction in EC was still evident in MP from patients 60 min after their exercise session (Fig. <xref rid="phy213825-fig-0005" ref-type="fig">5</xref>B) compared to MP taken at the same time at rest (delta change of 3.72 ± 4.04 compared to −5.99 ± 3.94 DCFHDA fluorescence units per 1000 MP; <italic>P</italic> &lt; 0.05). There were no differences between trial arms at the end of HD.</p>
                <fig fig-type="Figure" xml:lang="en" id="phy213825-fig-0005" orientation="portrait" position="float">
                  <label>Figure 5</label>
                  <caption>
                    <p>Microparticle induced reactive oxygen species in an endothelial cell line. <styled-content style="fixed-case">MP</styled-content> isolated from plasma samples were taken 60 min into <styled-content style="fixed-case">HD</styled-content>, immediately following exercise (open symbols) (or equivalent time in control group (closed symbols)) (A) and 60 min after exercise (equivalent to 160 min into dialysis for control group) (B) and were incubated with <styled-content style="fixed-case">EA</styled-content>.hy926 endothelial cells (<styled-content style="fixed-case">EC</styled-content>) which had been preloaded with 5 <italic>μ</italic>mol/L <styled-content style="fixed-case">DCFHDA</styled-content>. Reactive oxygen species (<styled-content style="fixed-case">ROS</styled-content>) generation was analyzed every 15 min for 120 min and then after 20 h using a fluorescent plate reader. All <styled-content style="fixed-case">ROS</styled-content> responses were adjusted to signal per 1000 <styled-content style="fixed-case">MP</styled-content> following <styled-content style="fixed-case">MP</styled-content> enumeration as described and delta changes were calculated relative to the sample taken 60 min into <styled-content style="fixed-case">HD</styled-content>. <styled-content style="fixed-case">MP</styled-content> from exercising patients, taken immediately after exercise induced significantly increased <styled-content style="fixed-case">ROS</styled-content> when incubated with <styled-content style="fixed-case">EC</styled-content> for 120 min (*<italic>P</italic> &lt; 0.05) compared to <styled-content style="fixed-case">MP</styled-content> collected from these patients at the same time at rest (A). Also, <styled-content style="fixed-case">MP</styled-content> taken from exercising patients 60 min after exercise induced significantly increased levels of <styled-content style="fixed-case">ROS</styled-content> when incubated with <styled-content style="fixed-case">EC</styled-content> at various time points (90 min: **, 105 min: ***, 120 min: ****, all <italic>P</italic> &lt; 0.05) compared to the response induced by <styled-content style="fixed-case">MP</styled-content> from patients at rest 160 min into <styled-content style="fixed-case">HD</styled-content> (B). All <italic>n</italic> = 5.</p>
                  </caption>
                  <graphic id="nlm-graphic-11" xlink:href="PHY2-6-e13825-g005"/>
                </fig>
              </sec>
            </sec>
            <sec id="phy213825-sec-0014">
              <title>Discussion</title>
              <p>This is the first study to comprehensively characterize the acute response of circulating MP to IDE during HD and to investigate the ability of these circulating MP to induce EC ROS in vitro. Our findings suggest that IDE at an intensity that can be sustained for 30 min does not exacerbate the effects of HD in increasing the number and phenotype of prothrombotic circulating MP. However, MP collected after IDE induced greater ROS production from cultured EC, suggesting an acute, short‐lived proinflammatory response; this could indicate the potential for chronic anti‐inflammatory adaptation with regular IDE. Given the association between MP, inflammation and endothelial dysfunction in CKD (Erdbrügger and Li <xref rid="phy213825-bib-0027" ref-type="ref">2016</xref>), the link between MP and cardiovascular mortality (Amabile et al. <xref rid="phy213825-bib-0002" ref-type="ref">2012</xref>) in HD patients, and the known anti‐inflammatory effects of exercise (Gleeson et al. <xref rid="phy213825-bib-0034" ref-type="ref">2011</xref>) these findings provide new insight into the effect of the HD process on cardiovascular risk in end stage renal disease and the impact of IDE on this risk.</p>
              <p>To the best of our knowledge, there are no other studies to date reporting enumeration of, or changes in, the total number of circulating MP during HD. Previous work by our group looking at total numbers of circulating MP in HD patients did not observe numbers during the HD process itself (Burton et al. <xref rid="phy213825-bib-0014" ref-type="ref">2013</xref>). In addition, this study used Nanoparticle‐tracking analysis to enumerate MP without any surface marker detection. We used flow cytometry with MP fluorescent intensity using size‐calibrated fluorescent beads is as a threshold for particle detection. This approach offers better separation from background noise, is less likely affected by aggregation of particles and might detect particles as low as 100–200 nm (Erdbrügger and Li <xref rid="phy213825-bib-0027" ref-type="ref">2016</xref>) and although one technique was used here to enumerate and analyze MP, recent publications assert that flow cytometry remains the most suitable method for determining the cellular origin on MP (Maas et al. <xref rid="phy213825-bib-0049" ref-type="ref">2015</xref>; Erdbrügger and Li <xref rid="phy213825-bib-0027" ref-type="ref">2016</xref>; Cointe et al. <xref rid="phy213825-bib-0017" ref-type="ref">2017</xref>). It was not possible for us to phenotype MP in this study using Western blotting due to the small sample volumes obtained (Pospichalova et al. <xref rid="phy213825-bib-0056" ref-type="ref">2015</xref>). A recent study highlighting the limitations of both Nanosight particle tracking analysis and tunable resistive pulse sensing (Maas et al. <xref rid="phy213825-bib-0049" ref-type="ref">2015</xref>) suggests that flow cytometry is the most sensitive and accurate method for enumeration of MP. Therefore, flow cytometry is the most appropriate method for the phenotypic enumeration analyses required to address the hypothesis of this study, and no other single method would provide such comprehensive information.</p>
              <p>Contact of blood with foreign materials and vascular shear stress during HD causes activation of immune cells, the complement system, cytokine production and release and oxidative stress (Amore and Coppo <xref rid="phy213825-bib-0003" ref-type="ref">2002</xref>) despite the dilution of uremic toxins. Subjecting blood to conditions simulating flow itself induces increases in MP numbers in vitro (Holtom et al. <xref rid="phy213825-bib-0039" ref-type="ref">2011</xref>), while adding uremic plasma (Dursun et al. <xref rid="phy213825-bib-0024" ref-type="ref">2009</xref>) or uremic toxins (Faure et al. <xref rid="phy213825-bib-0028" ref-type="ref">2006</xref>) to cultured EC cell lines induces endothelial dysfunction and MP release in vitro. Thus, it is of no surprise that we observed an acute increase in total MP numbers, although exercise performance had no effect, possibly due to the relatively low workload that patients were able to perform here. This is in line with our previous findings that the IDE used here has little impact on HD‐induced neutrophil activation and inflammatory cytokine release (Dungey et al. <xref rid="phy213825-bib-0022" ref-type="ref">2015</xref>). Other studies investigating the effects of exercise on MP have studied healthy younger subjects and used moderate‐vigorous incremental exercise protocols (Chaar et al. <xref rid="phy213825-bib-0015" ref-type="ref">2011</xref>; Wahl et al. <xref rid="phy213825-bib-0068" ref-type="ref">2014</xref>; Frühbeis et al. <xref rid="phy213825-bib-0030" ref-type="ref">2015</xref>) with exercise beginning at ~100 W. This far exceeds the capabilities of the patients studied here (average 22 W). Therefore, although the protocol used here did not induce many exercise‐related changes in <italic>numbers</italic> of MP, ours was a pragmatic approach geared toward assessing the responses to the exercise capabilities of our patient population.</p>
              <p>Changes in circulating prothrombotic MP were observed over the course of HD, but again no differences were detected between the exercising or resting study arms. The number of phosphatidylserine +MP increased over the course of HD yet the number of MP expressing tissue factor did not change, although there was a decrease in the proportion of these. Although phosphatidylserine and tissue factor are both considered prothrombotic molecules, recent research suggests that they have different roles in the coagulation process (Spronk et al. <xref rid="phy213825-bib-0064" ref-type="ref">2014</xref>), with phosphatidylserine considered a potent inducer of cell‐surface tissue factor conversion into its prothrombotic decrypted state (Rao et al. <xref rid="phy213825-bib-0059" ref-type="ref">2012</xref>). Therefore, the increase in phosphatidylserine+ MP may have subsequent prothrombotic impacts beyond the observation period of this study.</p>
              <p>The overall percentage of phosphatidylserine+MP remained unchanged both over the course of HD and during each arm of the study but, at an average of 4% phosphatidylserine+MP of the total MP population, was considerably lower than the 90% that has been previously reported in HD patients when not on dialysis (Trappenburg et al. <xref rid="phy213825-bib-0066" ref-type="ref">2012</xref>). Our values may reflect clearance during HD, but perhaps more likely to reflect methodological and definition variations known to cause discrepancies in MP numbers and indeed phosphatidylserine expression in earlier studies (Ayers et al. <xref rid="phy213825-bib-0005" ref-type="ref">2011</xref>; Erdbrügger and Li <xref rid="phy213825-bib-0027" ref-type="ref">2016</xref>). Values of around 11% phosphatidylserine+MP have been reported in healthy males (Nielsen et al. <xref rid="phy213825-bib-0051" ref-type="ref">2014</xref>). AnV is commonly used, as in this study, to detect surface expression of its phospholipid ligand, phosphatidylserine but it is not clear how much PS is externalized on MP and not all MP bind AnV (Erdbrügger and Li <xref rid="phy213825-bib-0027" ref-type="ref">2016</xref>). AnV and phosphatidylserine expression alone should not be used as a definitive marker for all MP, but should be applied to consider populations of both phosphatidylserine+ and phosphatidylserine− MP. Without consistency in definitions comparisons between studies remain difficult.</p>
              <p>Increased numbers of MP derived from platelets and EC are known to be associated with risk factors for CVD with EC‐derived MP predictive of all cause and CVD mortality in stable HD patients (Amabile et al. <xref rid="phy213825-bib-0002" ref-type="ref">2012</xref>). We found an increase in platelet‐derived CD42b+MP over the course of HD, irrespective of whether exercise had taken place or not. However, we found no changes in phosphatidylserine+CD42b+MP. Platelet‐derived CD41 + MP (Daniel et al. <xref rid="phy213825-bib-0021" ref-type="ref">2006</xref>; Faure et al. <xref rid="phy213825-bib-0028" ref-type="ref">2006</xref>) and CD42 + MP (Burton et al. <xref rid="phy213825-bib-0014" ref-type="ref">2013</xref>) have been shown to be increased in number in both nondialysis CKD and HD patients compared to healthy controls, and differences may be again related to the use of phosphatidylserine expression to define MP (Erdbrügger and Li <xref rid="phy213825-bib-0027" ref-type="ref">2016</xref>).</p>
              <p>We detected extremely low, or absent, circulating EC‐derived CD144 + MP in patients when resting or exercising during HD. Other investigations report decreases in CD41‐CD31 + MP (Boulanger and Dignat‐George <xref rid="phy213825-bib-0011" ref-type="ref">2011</xref>) and CD144 + MP (Trappenburg et al. <xref rid="phy213825-bib-0066" ref-type="ref">2012</xref>), or no changes in either CD144 + MP or CD146 + MP (Faure et al. <xref rid="phy213825-bib-0028" ref-type="ref">2006</xref>) following an HD session. CD144 and CD105 are the only constitutive markers of EC which are not found on other cell types (Latham et al. <xref rid="phy213825-bib-0048" ref-type="ref">2015</xref>) and although a variety of endothelial markers are used by groups studying EC‐derived MP, the dynamics, stimuli and mechanisms of EC MP formation are little understood (Curtis et al. <xref rid="phy213825-bib-0019" ref-type="ref">2013</xref>). It is thought that EC‐derived MP account for a very minor proportion of all circulating MP (Trappenburg et al. <xref rid="phy213825-bib-0066" ref-type="ref">2012</xref>); indeed, they have been described as “rare” (Tushuizen et al. <xref rid="phy213825-bib-0067" ref-type="ref">2011</xref>). While it might be expected that these MP would increase in number during HD because of shear stresses and endothelial activation, the decrease or absence found here and by other groups may be due to the restoration of viscosity and laminar shear stress during HD (Amabile et al. <xref rid="phy213825-bib-0001" ref-type="ref">2005</xref>) as high‐flux filtration has been shown to reduce the number of EC‐derived MP (Ramirez et al. <xref rid="phy213825-bib-0058" ref-type="ref">2007</xref>).</p>
              <p>MP effectively act as a storage pool of bioactive effectors (Hugel et al. <xref rid="phy213825-bib-0040" ref-type="ref">2005</xref>) and are known to induce EC ROS (Holtom et al. <xref rid="phy213825-bib-0039" ref-type="ref">2011</xref>). Here, we were able to detect ROS produced when EC were incubated with MP collected up to 60 min after exercise, but not with MP derived from the end of HD or from any MP samples taken when these patients were resting during HD. While endothelial ROS act as important second messengers within the cells, an imbalance between ROS generation and innate antioxidant defences represents the primary cause of endothelial dysfunction and the initiation of vascular diseases (Chen et al. <xref rid="phy213825-bib-0016" ref-type="ref">2018</xref>). The consequences of sustained increases in EC ROS production include the recruitment of inflammatory cells, proinflammatory cytokine release, reduced nitric oxide vasodilatory activity, enhanced formation of the deleterious radical, peroxynitrite and cell death (El Assar et al. <xref rid="phy213825-bib-0026" ref-type="ref">2013</xref>; Barhoumi et al. <xref rid="phy213825-bib-0006" ref-type="ref">2014</xref>). However, here the effect was short‐lived (&lt;2 h). Acute, transient proinflammatory events lasting only a few hours are a key stimulus for longer‐term adaptations to regular exercise that are associated with reduced CVD risk (Gleeson et al. <xref rid="phy213825-bib-0034" ref-type="ref">2011</xref>). In support of this, mouse EC subjected to laminar shear stress exhibited enhanced NADPH oxidase subunit expression which was reduced after 2 weeks of moderate intensity aerobic training (Robinson et al. <xref rid="phy213825-bib-0061" ref-type="ref">2017</xref>) and EPO‐enhanced ROS generation and monocyte/macrophage infiltration were alleviated after 8 weeks of moderate intensity aerobic exercise in mice with endothelin‐1 overexpression (Barhoumi et al. <xref rid="phy213825-bib-0006" ref-type="ref">2014</xref>). Furthermore, enhanced in vivo NADPH oxidase‐derived ROS production from EC in the muscle microvasculature was attenuated after 8 weeks of moderate intensity aerobic training in sedentary obese populations (La Favor et al. <xref rid="phy213825-bib-0046" ref-type="ref">2016</xref>). The transient, yet enhanced, ROS production from EC cultured with post‐exercise MP could reflect an initial stimulus for this positive adaptive process but it must be acknowledged that the small sample size does not allow definitive conclusions to be made.</p>
              <p>Given the pragmatic approach of this study some limitations must be acknowledged. The randomized‐crossover design allows direct comparisons to be made between the two trial arms and reduces the potential impact of confounding elements such as circadian rhythm. The sample size precludes definitive conclusions from being made but does provide crucial data to inform the design of future investigations. Patients eligible to take part in exercise were healthier with a lower risk of complications and while the first sample was taken before exercise, this was 60 min into HD. This was to allow for patient stabilization and to avoid interference of routine HD set‐up, but it is certainly possible that increases in MP occurred in that first hour. However, the purpose of this study was to determine the effects of an acute session of IDE on MP responses, not the effects of HD per se. Furthermore, although patients involved in this study had been taking part in the IDE program for at least 3 months, this was not a longitudinal study. The longer‐term effects of IDE on MP responses are still unknown. However, a recent study in renal transplant recipients reported no changes in circulating phosphatidylserine+MP after 6 months of aerobic training yet observed a significant increase in prothrombotic MP in non‐exercising recipients, perhaps indicating an adaptive amelioration of vascular activation in the exercising group (Pitha et al. <xref rid="phy213825-bib-0055" ref-type="ref">2015</xref>).</p>
              <p>In summary, given the known inflammatory properties of MP these novel findings indicate that an acute session of moderate intensity IDE does not add further to the heavy inflammatory burden of HD, extending our previous findings (Dungey et al. <xref rid="phy213825-bib-0022" ref-type="ref">2015</xref>). However, acute proinflammatory responses to exercise are an avenue for the development of a longer term anti‐inflammatory adaptation (Gleeson et al. <xref rid="phy213825-bib-0034" ref-type="ref">2011</xref>). The ability of MP collected immediately and 60 min after exercise (but not later than this) to induce a transient amplification of EC ROS production in vitro may indicate the potential for a longer‐term positive adaptive effect of regular IDE on endothelial cell function. Given the exceptionally high risk of CVD in these patients, these novel findings provide an evidence‐base for future study of the long‐term effects of regular IDE on MP phenotype and prothrombotic properties.</p>
            </sec>
            <sec id="phy213825-sec-0016">
              <title>Conflict of Interest</title>
              <p>Outside the submitted work Reck UK funded MRD, HMLY, and JOB to attend the 2012 BMJ Awards. There are no other financial conflicts of interest. The results presented in this paper have not been published previously in whole or part, except in abstract format, at the 2016 European Renal Association‐European Dialysis and Transplant Association Meeting.</p>
            </sec>
          </body>
          <back>
            <ack id="phy213825-sec-0015">
              <title>Acknowledgments</title>
              <p>We thank the staff and patients who gave up their time to participate in the study, and the Leicester Kidney Care Appeal for their support of the study and the exercise program. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. Current affiliation for Naomi Martin: School of Allied Health Sciences, De Montfort University, Leicester.</p>
            </ack>
            <ref-list content-type="cited-references" id="phy213825-bibl-0001">
              <title>References</title>
              <ref id="phy213825-bib-0001">
                <mixed-citation publication-type="journal" id="phy213825-cit-0001"><string-name><surname>Amabile</surname>, <given-names>N.</given-names></string-name>, <string-name><given-names>A. P.</given-names><surname>Guérin</surname></string-name>, <string-name><given-names>A.</given-names><surname>Leroyer</surname></string-name>, <string-name><given-names>Z.</given-names><surname>Mallat</surname></string-name>, <string-name><given-names>C.</given-names><surname>Nguyen</surname></string-name>, <string-name><given-names>J.</given-names><surname>Boddaert</surname></string-name>, et al. <year>2005</year>
<article-title>Circulating endothelial microparticles are associated with vascular dysfunction in patients with end‐stage renal failure</article-title>. <source xml:lang="en">J. Am. Soc. Nephrol.</source>
<volume>16</volume>:<fpage>3381</fpage>–<lpage>3388</lpage>.<pub-id pub-id-type="pmid">16192427</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0002">
                <mixed-citation publication-type="journal" id="phy213825-cit-0002"><string-name><surname>Amabile</surname>, <given-names>N.</given-names></string-name>, <string-name><given-names>A. P.</given-names><surname>Guérin</surname></string-name>, <string-name><given-names>A.</given-names><surname>Tedgui</surname></string-name>, <string-name><given-names>C. M.</given-names><surname>Boulanger</surname></string-name>, and <string-name><given-names>G. M.</given-names><surname>London</surname></string-name>. <year>2012</year><article-title>Predictive value of circulating endothelial microparticles for cardiovascular mortality in end‐stage renal failure: a pilot study</article-title>. <source xml:lang="en">Nephrol. Dial. Transplant.</source><volume>27</volume>:<fpage>1873</fpage>–<lpage>1880</lpage>.<pub-id pub-id-type="pmid">22036944</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0003">
                <mixed-citation publication-type="journal" id="phy213825-cit-0003"><string-name><surname>Amore</surname>, <given-names>A.</given-names></string-name>, and <string-name><given-names>R.</given-names><surname>Coppo</surname></string-name>. <year>2002</year><article-title>Immunological basis of inflammation in dialysis</article-title>. <source xml:lang="en">Nephrol. Dial. Transplant.</source><volume>17</volume>:<fpage>16</fpage>–<lpage>24</lpage>.</mixed-citation>
              </ref>
              <ref id="phy213825-bib-0004">
                <mixed-citation publication-type="journal" id="phy213825-cit-0004"><string-name><surname>Ashman</surname>, <given-names>N.</given-names></string-name>, <string-name><given-names>M. G.</given-names><surname>Macey</surname></string-name>, <string-name><given-names>S. L.</given-names><surname>Fan</surname></string-name>, <string-name><given-names>U.</given-names><surname>Azam</surname></string-name>, and <string-name><given-names>M. M.</given-names><surname>Yaqoob</surname></string-name>. <year>2003</year><article-title>Increased platelet‐monocyte aggregates and cardiovascular disease in end‐stage renal failure patients</article-title>. <source xml:lang="en">Nephrol. Dial. Transplant.</source><volume>18</volume>:<fpage>2088</fpage>–<lpage>2096</lpage>.<pub-id pub-id-type="pmid">13679485</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0005">
                <mixed-citation publication-type="journal" id="phy213825-cit-0005"><string-name><surname>Ayers</surname>, <given-names>L.</given-names></string-name>, <string-name><given-names>M.</given-names><surname>Kohler</surname></string-name>, <string-name><given-names>P.</given-names><surname>Harrison</surname></string-name>, <string-name><given-names>I.</given-names><surname>Sargent</surname></string-name>, <string-name><given-names>R.</given-names><surname>Dragovic</surname></string-name>, <string-name><given-names>M.</given-names><surname>Schaap</surname></string-name>, et al. <year>2011</year>
<article-title>Measurement of circulating cell‐derived microparticles by flow‐cytometry: sources of variability within the assay</article-title>. <source xml:lang="en">Thromb. Res.</source>
<volume>127</volume>:<fpage>370</fpage>–<lpage>377</lpage>.<pub-id pub-id-type="pmid">21257195</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0006">
                <mixed-citation publication-type="journal" id="phy213825-cit-0006"><string-name><surname>Barhoumi</surname>, <given-names>T.</given-names></string-name>, <string-name><given-names>M.</given-names><surname>Briet</surname></string-name>, <string-name><given-names>D. A.</given-names><surname>Kasal</surname></string-name>, <string-name><given-names>J. C.</given-names><surname>Fraulob‐Aquino</surname></string-name>, <string-name><given-names>N.</given-names><surname>Idris‐Khodja</surname></string-name>, <string-name><given-names>P.</given-names><surname>Laurant</surname></string-name>, et al. <year>2014</year>
<article-title>Erythropoietin‐induced hypertension and vascular injury in mice overexpressing human endothelin‐1: exercise attenuated hypertension, oxidative stress, inflammation and immune response</article-title>. <source xml:lang="en">J. Hypertens.</source>
<volume>32</volume>:<fpage>784</fpage>–<lpage>794</lpage>.<pub-id pub-id-type="pmid">24463938</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0007">
                <mixed-citation publication-type="journal" id="phy213825-cit-0007"><string-name><surname>Barry</surname>, <given-names>O. P.</given-names></string-name>, <string-name><given-names>D.</given-names><surname>Pratico</surname></string-name>, <string-name><given-names>R. C.</given-names><surname>Savani</surname></string-name>, and <string-name><given-names>G. A.</given-names><surname>Fitzgerald</surname></string-name>. <year>1998</year><article-title>Modulation of monocyte–endothelial cell interactions by platelet microparticles</article-title>. <source xml:lang="en">J. Clin. Invest.</source><volume>102</volume>:<fpage>136</fpage>–<lpage>144</lpage>.<pub-id pub-id-type="pmid">9649567</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0008">
                <mixed-citation publication-type="journal" id="phy213825-cit-0008"><string-name><surname>Barteneva</surname>, <given-names>N. S.</given-names></string-name>, <string-name><given-names>E.</given-names><surname>Fasler‐Kan</surname></string-name>, <string-name><given-names>M.</given-names><surname>Bernimoulin</surname></string-name>, <string-name><given-names>J. N. H.</given-names><surname>Stern</surname></string-name>, <string-name><given-names>E. D.</given-names><surname>Ponomarev</surname></string-name>, <string-name><given-names>L.</given-names><surname>Duckett</surname></string-name>, et al. <year>2013</year>
<article-title>Circulating microparticles: square the circle</article-title>. <source xml:lang="en">BMC Cell Biol.</source>
<volume>14</volume>:<fpage>23</fpage>–<lpage>44</lpage>.<pub-id pub-id-type="pmid">23607880</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0009">
                <mixed-citation publication-type="journal" id="phy213825-cit-0009"><string-name><surname>Betjes</surname>, <given-names>M.</given-names></string-name><year>2013</year><article-title>Immune cell dysfunction and inflammation in end‐stage renal disease</article-title>. <source xml:lang="en">Nat. Rev. Nephrol.</source><volume>9</volume>:<fpage>255</fpage>–<lpage>265</lpage>.<pub-id pub-id-type="pmid">23507826</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0010">
                <mixed-citation publication-type="journal" id="phy213825-cit-0010"><string-name><surname>Borg</surname>, <given-names>G. A. V.</given-names></string-name><year>1973</year><article-title>Perceived exertion: a note on “history” and methods</article-title>. <source xml:lang="en">Med. Sci. Sports Exerc.</source><volume>5</volume>:<fpage>90</fpage>–<lpage>93</lpage>.</mixed-citation>
              </ref>
              <ref id="phy213825-bib-0011">
                <mixed-citation publication-type="journal" id="phy213825-cit-0011"><string-name><surname>Boulanger</surname>, <given-names>C. M.</given-names></string-name>, and <string-name><given-names>F.</given-names><surname>Dignat‐George</surname></string-name>. <year>2011</year><article-title>Microparticles: an introduction</article-title>. <source xml:lang="en">Arterioscler. Thromb. Vasc. Biol.</source><volume>31</volume>:<fpage>2</fpage>–<lpage>3</lpage>.<pub-id pub-id-type="pmid">21160061</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0012">
                <mixed-citation publication-type="journal" id="phy213825-cit-0012"><string-name><surname>Boulanger</surname>, <given-names>C. M.</given-names></string-name>, <string-name><given-names>N.</given-names><surname>Amabile</surname></string-name>, <string-name><given-names>A. P.</given-names><surname>Guérin</surname></string-name>, <string-name><given-names>B.</given-names><surname>Pannier</surname></string-name>, <string-name><given-names>A. S.</given-names><surname>Leroyer</surname></string-name>, <string-name><given-names>C. N.</given-names><surname>Mallat</surname></string-name>, et al. <year>2007</year>
<article-title>In vivo shear stress determines circulating levels of endothelial microparticles in end‐stage renal disease</article-title>. <source xml:lang="en">Hypertension</source>
<volume>9</volume>:<fpage>902</fpage>–<lpage>908</lpage>.</mixed-citation>
              </ref>
              <ref id="phy213825-bib-0013">
                <mixed-citation publication-type="journal" id="phy213825-cit-0013"><string-name><surname>Burton</surname>, <given-names>J. O.</given-names></string-name>, <string-name><given-names>H. J.</given-names><surname>Jefferies</surname></string-name>, <string-name><given-names>N. M.</given-names><surname>Selby</surname></string-name>, and <string-name><given-names>C. W.</given-names><surname>McIntyre</surname></string-name>. <year>2009</year><article-title>Hemodialysis‐induced cardiac injury: determinants and associated outcomes</article-title>. <source xml:lang="en">Clin. J. Am. Soc. Nephrol.</source><volume>4</volume>:<fpage>914</fpage>–<lpage>920</lpage>.<pub-id pub-id-type="pmid">19357245</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0014">
                <mixed-citation publication-type="journal" id="phy213825-cit-0014"><string-name><surname>Burton</surname>, <given-names>J. O.</given-names></string-name>, <string-name><given-names>H. A.</given-names><surname>Hamali</surname></string-name>, <string-name><given-names>R.</given-names><surname>Singh</surname></string-name>, <string-name><given-names>N.</given-names><surname>Abbasian</surname></string-name>, <string-name><given-names>R.</given-names><surname>Parsons</surname></string-name>, <string-name><given-names>A. K.</given-names><surname>Patel</surname></string-name>, et al. <year>2013</year>
<article-title>Elevated levels of procoagulant plasma microvesicles in dialysis patients</article-title>. <source xml:lang="en">PLoS ONE</source>
<volume>8</volume>:<fpage>e72663</fpage>.<pub-id pub-id-type="pmid">23936542</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0015">
                <mixed-citation publication-type="journal" id="phy213825-cit-0015"><string-name><surname>Chaar</surname>, <given-names>V.</given-names></string-name>, <string-name><given-names>M.</given-names><surname>Romana</surname></string-name>, <string-name><given-names>J.</given-names><surname>Tripette</surname></string-name>, <string-name><given-names>C.</given-names><surname>Broquere</surname></string-name>, <string-name><given-names>M. G.</given-names><surname>Huisse</surname></string-name>, <string-name><given-names>O.</given-names><surname>Hue</surname></string-name>, et al. <year>2011</year>
<article-title>Effect of strenuous physical exercise on circulating cell‐derived microparticles</article-title>. <source xml:lang="en">Clin. Hemorheol. Microcirc.</source>
<volume>47</volume>:<fpage>15</fpage>–<lpage>25</lpage>.<pub-id pub-id-type="pmid">21321404</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0016">
                <mixed-citation publication-type="journal" id="phy213825-cit-0016"><string-name><surname>Chen</surname>, <given-names>Q.</given-names></string-name>, <string-name><given-names>Q.</given-names><surname>Wang</surname></string-name>, <string-name><given-names>J.</given-names><surname>Zhu</surname></string-name>, <string-name><given-names>Q.</given-names><surname>Xiao</surname></string-name>, and <string-name><given-names>L.</given-names><surname>Zhang</surname></string-name>. <year>2018</year><article-title>Reactive oxygen species: key regulators in vascular health and diseases</article-title>. <source xml:lang="en">Br. J. Pharmacol.</source><volume>175</volume>:<fpage>1279</fpage>–<lpage>1292</lpage>. <pub-id pub-id-type="doi">10.1111/bph.13828</pub-id>
<pub-id pub-id-type="pmid">28430357</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0017">
                <mixed-citation publication-type="journal" id="phy213825-cit-0017"><string-name><surname>Cointe</surname>, <given-names>S.</given-names></string-name>, <string-name><given-names>C.</given-names><surname>Judicone</surname></string-name>, <string-name><given-names>S.</given-names><surname>Robert</surname></string-name>, <string-name><given-names>M. J.</given-names><surname>Mooberry</surname></string-name>, <string-name><given-names>P.</given-names><surname>Poncelet</surname></string-name>, <string-name><given-names>M.</given-names><surname>Wauben</surname></string-name>, et al. <year>2017</year>
<article-title>Standardization of microparticle enumeration across different flow cytometry platforms: results of a multicentre collaborative workshop</article-title>. <source xml:lang="en">J. Thromb. Haemost.</source>
<volume>15</volume>:<fpage>187</fpage>–<lpage>193</lpage>.<pub-id pub-id-type="pmid">27662257</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0018">
                <mixed-citation publication-type="journal" id="phy213825-cit-0018"><string-name><surname>Costa</surname>, <given-names>E.</given-names></string-name>, <string-name><given-names>M.</given-names><surname>Lima</surname></string-name>, <string-name><given-names>J. M.</given-names><surname>Alves</surname></string-name>, <string-name><given-names>S.</given-names><surname>Rocha</surname></string-name>, <string-name><given-names>P.</given-names><surname>Rocha‐Pereira</surname></string-name>, <string-name><given-names>E.</given-names><surname>Castro</surname></string-name>, et al. <year>2008</year>
<article-title>Inflammation, T‐Cell phenotype, and inflammatory cytokines in chronic kidney disease patients under hemodialysis and its relationship to resistance to recombinant human erythropoietin therapy</article-title>. <source xml:lang="en">J. Clin. Immunol.</source>
<volume>28</volume>:<fpage>268</fpage>–<lpage>275</lpage>.<pub-id pub-id-type="pmid">18205031</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0019">
                <mixed-citation publication-type="journal" id="phy213825-cit-0019"><string-name><surname>Curtis</surname>, <given-names>A. M.</given-names></string-name>, <string-name><given-names>J.</given-names><surname>Edelberg</surname></string-name>, <string-name><given-names>R.</given-names><surname>Jonas</surname></string-name>, <string-name><given-names>W. T.</given-names><surname>Rogers</surname></string-name>, <string-name><given-names>J. S.</given-names><surname>Moore</surname></string-name>, <string-name><given-names>W.</given-names><surname>Syed</surname></string-name>, et al. <year>2013</year>
<article-title>Endothelial microparticles: sophisticated vesicles modulating vascular function</article-title>. <source xml:lang="en">Vasc. Med.</source>
<volume>18</volume>:<fpage>204</fpage>–<lpage>214</lpage>.<pub-id pub-id-type="pmid">23892447</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0020">
                <mixed-citation publication-type="journal" id="phy213825-cit-0020"><string-name><surname>Dalrymple</surname>, <given-names>L. S.</given-names></string-name>, and <string-name><given-names>A. S.</given-names><surname>Go</surname></string-name>. <year>2008</year><article-title>Epidemiology of acute infections among patients with chronic kidney disease</article-title>. <source xml:lang="en">Clin. J. Am. Soc. Nephrol.</source><volume>3</volume>:<fpage>1487</fpage>–<lpage>1493</lpage>.<pub-id pub-id-type="pmid">18650409</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0021">
                <mixed-citation publication-type="journal" id="phy213825-cit-0021"><string-name><surname>Daniel</surname>, <given-names>L.</given-names></string-name>, <string-name><given-names>F.</given-names><surname>Fakhouri</surname></string-name>, <string-name><given-names>D.</given-names><surname>Joly</surname></string-name>, <string-name><given-names>L.</given-names><surname>Mouthon</surname></string-name>, <string-name><given-names>P.</given-names><surname>Nusbaum</surname></string-name>, <string-name><given-names>J. P.</given-names><surname>Grunfeld</surname></string-name>, et al. <year>2006</year>
<article-title>Increase in circulating neutrophil and platelet microparticles during acute vasculitis and hemodialysis</article-title>. <source xml:lang="en">Kidney Int.</source>
<volume>69</volume>:<fpage>1416</fpage>–<lpage>1423</lpage>.<pub-id pub-id-type="pmid">16531979</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0022">
                <mixed-citation publication-type="journal" id="phy213825-cit-0022"><string-name><surname>Dungey</surname>, <given-names>M.</given-names></string-name>, <string-name><given-names>N. C.</given-names><surname>Bishop</surname></string-name>, <string-name><given-names>H. M. L.</given-names><surname>Young</surname></string-name>, <string-name><given-names>J. O.</given-names><surname>Burton</surname></string-name>, and <string-name><given-names>A. C.</given-names><surname>Smith</surname></string-name>. <year>2015</year><article-title>The impact of exercising during haemodialysis on blood pressure, markers of cardiac injury and systemic inflammation – preliminary results of a pilot study</article-title>. <source xml:lang="en">Kidney Blood Press. Res.</source><volume>40</volume>:<fpage>593</fpage>–<lpage>604</lpage>.<pub-id pub-id-type="pmid">26619202</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0023">
                <mixed-citation publication-type="journal" id="phy213825-cit-0023"><string-name><surname>Dungey</surname>, <given-names>M.</given-names></string-name>, <string-name><given-names>H. M. L.</given-names><surname>Young</surname></string-name>, <string-name><given-names>D. R.</given-names><surname>Churchward</surname></string-name>, <string-name><given-names>J. O.</given-names><surname>Burton</surname></string-name>, <string-name><given-names>A. C.</given-names><surname>Smith</surname></string-name>, and <string-name><given-names>N. C.</given-names><surname>Bishop</surname></string-name>. <year>2017</year><article-title>Regular exercise during haemodialysis promotes an anti‐inflammatory leucocyte profile</article-title>. <source xml:lang="en">Clin Kidney J</source><volume>10</volume>:<fpage>813</fpage>–<lpage>821</lpage>.<pub-id pub-id-type="pmid">29225811</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0024">
                <mixed-citation publication-type="journal" id="phy213825-cit-0024"><string-name><surname>Dursun</surname>, <given-names>I.</given-names></string-name>, <string-name><given-names>H. M.</given-names><surname>Poyrazoglu</surname></string-name>, <string-name><given-names>Z.</given-names><surname>Gunduz</surname></string-name>, <string-name><given-names>H.</given-names><surname>Ulger</surname></string-name>, <string-name><given-names>A.</given-names><surname>Yykylmaz</surname></string-name>, <string-name><given-names>R.</given-names><surname>Dusunsel</surname></string-name>, et al. <year>2009</year>
<article-title>The relationship between circulating endothelial microparticles and arterial stiffness and atherosclerosis in children with chronic kidney disease</article-title>. <source xml:lang="en">Nephrol. Dial. Transplant.</source>
<volume>24</volume>:<fpage>2511</fpage>–<lpage>2518</lpage>.<pub-id pub-id-type="pmid">19244228</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0025">
                <mixed-citation publication-type="journal" id="phy213825-cit-0025"><string-name><surname>Eckardt</surname>, <given-names>K. U.</given-names></string-name>, <string-name><given-names>J.</given-names><surname>Coresh</surname></string-name>, <string-name><given-names>O.</given-names><surname>Devuyst</surname></string-name>, <string-name><given-names>R. J.</given-names><surname>Johnson</surname></string-name>, <string-name><given-names>A.</given-names><surname>Köttgen</surname></string-name>, <string-name><given-names>A. S.</given-names><surname>Levey</surname></string-name>, et al. <year>2013</year>
<article-title>Evolving importance of kidney disease: from subspeciality to global health burden</article-title>. <source xml:lang="en">Lancet</source>
<volume>382</volume>:<fpage>158</fpage>–<lpage>169</lpage>.<pub-id pub-id-type="pmid">23727165</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0026">
                <mixed-citation publication-type="journal" id="phy213825-cit-0026"><string-name><surname>El Assar</surname>, <given-names>M.</given-names></string-name>, <string-name><given-names>J.</given-names><surname>Angulo</surname></string-name>, and <string-name><given-names>L.</given-names><surname>Rodríguez‐Mañas</surname></string-name>. <year>2013</year><article-title>Oxidative stress and vascular inflammation in aging</article-title>. <source xml:lang="en">Free Radic. Biol. Med.</source><volume>65</volume>:<fpage>380</fpage>–<lpage>401</lpage>.<pub-id pub-id-type="pmid">23851032</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0027">
                <mixed-citation publication-type="journal" id="phy213825-cit-0027"><string-name><surname>Erdbrügger</surname>, <given-names>U.</given-names></string-name>, and <string-name><given-names>T. H.</given-names><surname>Li</surname></string-name>. <year>2016</year><article-title>Extracellular vesicles in renal diseases: more than novel biomarkers?</article-title><source xml:lang="en">J. Am. Soc. Nephrol.</source><volume>27</volume>:<fpage>12</fpage>–<lpage>26</lpage>.<pub-id pub-id-type="pmid">26251351</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0028">
                <mixed-citation publication-type="journal" id="phy213825-cit-0028"><string-name><surname>Faure</surname>, <given-names>V.</given-names></string-name>, <string-name><given-names>L.</given-names><surname>Dou</surname></string-name>, <string-name><given-names>F.</given-names><surname>Sabatier</surname></string-name>, <string-name><given-names>C.</given-names><surname>Cerini</surname></string-name>, <string-name><given-names>J.</given-names><surname>Sampol</surname></string-name>, <string-name><given-names>Y.</given-names><surname>Berland</surname></string-name>, et al. <year>2006</year>
<article-title>Elevation of circulating endothelial microparticles in patients with chronic renal failure</article-title>. <source xml:lang="en">J. Thromb. Haemost.</source>
<volume>4</volume>:<fpage>566</fpage>–<lpage>573</lpage>.<pub-id pub-id-type="pmid">16405517</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0029">
                <mixed-citation publication-type="journal" id="phy213825-cit-0029"><string-name><surname>Forlow</surname>, <given-names>S. B.</given-names></string-name>, <string-name><given-names>R. P.</given-names><surname>McEver</surname></string-name>, and <string-name><given-names>M. U.</given-names><surname>Nollert</surname></string-name>. <year>2000</year><article-title>Leukocyte‐leukocyte interactions mediated by platelet microparticles under flow</article-title>. <source xml:lang="en">Blood</source><volume>95</volume>:<fpage>1317</fpage>–<lpage>1323</lpage>.<pub-id pub-id-type="pmid">10666205</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0030">
                <mixed-citation publication-type="journal" id="phy213825-cit-0030"><string-name><surname>Frühbeis</surname>, <given-names>C.</given-names></string-name>, <string-name><given-names>S.</given-names><surname>Helmig</surname></string-name>, <string-name><given-names>S.</given-names><surname>Tug</surname></string-name>, <string-name><given-names>P.</given-names><surname>Simon</surname></string-name>, and <string-name><given-names>E. M.</given-names><surname>Krämer‐Albers</surname></string-name>. <year>2015</year><article-title>Physical exercise induces rapid release of small extracellular vesicles into the circulation</article-title>. <source xml:lang="en">J. Extracell Vesicles</source><volume>4</volume>:<fpage>28239</fpage>.<pub-id pub-id-type="pmid">26142461</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0031">
                <mixed-citation publication-type="journal" id="phy213825-cit-0031"><string-name><surname>Gao</surname>, <given-names>C.</given-names></string-name>, <string-name><given-names>R.</given-names><surname>Xie</surname></string-name>, <string-name><given-names>C.</given-names><surname>Yu</surname></string-name>, <string-name><given-names>R.</given-names><surname>Ma</surname></string-name>, <string-name><given-names>Y.</given-names><surname>Dong</surname></string-name>, <string-name><given-names>H.</given-names><surname>Meng</surname></string-name>, et al. <year>2015</year>
<article-title>Thrombotic role of blood and endothelial cells in uremia through phosphatidylserine exposure and microparticle release</article-title>. <source xml:lang="en">PLoS ONE</source>
<volume>10</volume>:<fpage>1</fpage>–<lpage>16</lpage>.</mixed-citation>
              </ref>
              <ref id="phy213825-bib-0032">
                <mixed-citation publication-type="journal" id="phy213825-cit-0032"><string-name><surname>Girndt</surname>, <given-names>M.</given-names></string-name>, <string-name><given-names>H.</given-names><surname>Kohler</surname></string-name>, <string-name><given-names>E.</given-names><surname>Schiedhelm‐Weick</surname></string-name>, <string-name><given-names>J. F.</given-names><surname>Schlaak</surname></string-name>, <string-name><given-names>K. H.</given-names><surname>Meyer zum Buschenfelde</surname></string-name>, and <string-name><given-names>B.</given-names><surname>Fleischer</surname></string-name>. <year>1995</year><article-title>Production of interleukin‐6, tumor necrosis factor alpha and interleukin‐10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients</article-title>. <source xml:lang="en">Kidney Int.</source><volume>47</volume>:<fpage>559</fpage>–<lpage>565</lpage>.<pub-id pub-id-type="pmid">7723241</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0033">
                <mixed-citation publication-type="journal" id="phy213825-cit-0033"><string-name><surname>Girndt</surname>, <given-names>M.</given-names></string-name>, <string-name><given-names>M.</given-names><surname>Sester</surname></string-name>, <string-name><given-names>U.</given-names><surname>Sester</surname></string-name>, <string-name><given-names>H.</given-names><surname>Kaul</surname></string-name>, and <string-name><given-names>H.</given-names><surname>Köhler</surname></string-name>. <year>2001</year><article-title>Molecular aspects of T‐ and B‐cell function in uremia</article-title>. <source xml:lang="en">Kidney Int.</source><volume>78</volume>:<fpage>S206</fpage>–<lpage>S211</lpage>.</mixed-citation>
              </ref>
              <ref id="phy213825-bib-0034">
                <mixed-citation publication-type="journal" id="phy213825-cit-0034"><string-name><surname>Gleeson</surname>, <given-names>M.</given-names></string-name>, <string-name><given-names>N. C.</given-names><surname>Bishop</surname></string-name>, <string-name><given-names>D. J.</given-names><surname>Stensel</surname></string-name>, <string-name><given-names>M. R.</given-names><surname>Lindley</surname></string-name>, <string-name><given-names>S. S.</given-names><surname>Mastana</surname></string-name>, and <string-name><given-names>M. A.</given-names><surname>Nimmo</surname></string-name>. <year>2011</year><article-title>The anti‐inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease</article-title>. <source xml:lang="en">Nat. Rev. Immunol.</source><volume>11</volume>:<fpage>607</fpage>–<lpage>615</lpage>.<pub-id pub-id-type="pmid">21818123</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0035">
                <mixed-citation publication-type="journal" id="phy213825-cit-0035"><string-name><surname>Gollapudi</surname>, <given-names>P.</given-names></string-name>, <string-name><given-names>J. W.</given-names><surname>Yoon</surname></string-name>, <string-name><given-names>S.</given-names><surname>Gollapudi</surname></string-name>, <string-name><given-names>M. V.</given-names><surname>Pahl</surname></string-name>, and <string-name><given-names>N. D.</given-names><surname>Vaziri</surname></string-name>. <year>2010</year><article-title>Leukocyte toll‐like receptor expression in end‐stage kidney disease</article-title>. <source xml:lang="en">Am. J. Nephrol.</source><volume>31</volume>:<fpage>247</fpage>–<lpage>254</lpage>.<pub-id pub-id-type="pmid">20090311</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0036">
                <mixed-citation publication-type="journal" id="phy213825-cit-0036"><string-name><surname>Heine</surname>, <given-names>G. H.</given-names></string-name>, <string-name><given-names>A.</given-names><surname>Ortiz</surname></string-name>, <string-name><given-names>Z. A.</given-names><surname>Massy</surname></string-name>, <string-name><given-names>B.</given-names><surname>Lindholm</surname></string-name>, <string-name><given-names>A.</given-names><surname>Wiecek</surname></string-name>, <string-name><given-names>A.</given-names><surname>Martines‐Castelao</surname></string-name>, et al. <year>2012</year>
<article-title>Monocyte subpopulations and cardiovascular risk in chronic kidney disease</article-title>. <source xml:lang="en">Nat. Rev. Nephrol.</source>
<volume>8</volume>:<fpage>362</fpage>–<lpage>369</lpage>.<pub-id pub-id-type="pmid">22410492</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0037">
                <mixed-citation publication-type="journal" id="phy213825-cit-0037"><string-name><surname>Heiwe</surname>, <given-names>S.</given-names></string-name>, and <string-name><given-names>S. H.</given-names><surname>Jacobson</surname></string-name>. <year>2014</year><article-title>Exercise training in adults with CKD: a systematic review and meta‐analysis</article-title>. <source xml:lang="en">Am. J. Kidney Dis.</source><volume>64</volume>:<fpage>383</fpage>–<lpage>393</lpage>.<pub-id pub-id-type="pmid">24913219</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0038">
                <mixed-citation publication-type="journal" id="phy213825-cit-0038"><string-name><surname>Holm</surname>, <given-names>S.</given-names></string-name><year>1979</year><article-title>Simple sequentially rejective multiple test procedure</article-title>. <source xml:lang="en">Scand. J. Statist.</source><volume>6</volume>:<fpage>65</fpage>–<lpage>70</lpage>.</mixed-citation>
              </ref>
              <ref id="phy213825-bib-0039">
                <mixed-citation publication-type="journal" id="phy213825-cit-0039"><string-name><surname>Holtom</surname>, <given-names>E.</given-names></string-name>, <string-name><given-names>J. R.</given-names><surname>Usherwood</surname></string-name>, <string-name><given-names>M. G.</given-names><surname>Macey</surname></string-name>, and <string-name><given-names>C.</given-names><surname>Lawson</surname></string-name>. <year>2011</year><article-title>Microparticle formation after co‐culture of human whole blood and umbilical artery in a novel in vitro model of flow</article-title>. <source xml:lang="en">Cytometry</source><volume>81A</volume>:<fpage>390</fpage>–<lpage>399</lpage>.</mixed-citation>
              </ref>
              <ref id="phy213825-bib-0040">
                <mixed-citation publication-type="journal" id="phy213825-cit-0040"><string-name><surname>Hugel</surname>, <given-names>B.</given-names></string-name>, <string-name><given-names>M. C.</given-names><surname>Martinez</surname></string-name>, <string-name><given-names>C.</given-names><surname>Kunzelmann</surname></string-name>, and <string-name><given-names>J. M.</given-names><surname>Freyssinet</surname></string-name>. <year>2005</year><article-title>Membrane microparticles: two sides of the coin</article-title>. <source xml:lang="en">Physiology</source><volume>20</volume>:<fpage>22</fpage>–<lpage>27</lpage>.<pub-id pub-id-type="pmid">15653836</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0041">
                <mixed-citation publication-type="journal" id="phy213825-cit-0041"><string-name><surname>Johansen</surname>, <given-names>K. L.</given-names></string-name>, <string-name><given-names>G. M.</given-names><surname>Chertow</surname></string-name>, <string-name><given-names>A. V.</given-names><surname>Ng</surname></string-name>, <string-name><given-names>K.</given-names><surname>Mulligan</surname></string-name>, <string-name><given-names>S.</given-names><surname>Carey</surname></string-name>, <string-name><given-names>P. Y.</given-names><surname>Schoenfeld</surname></string-name>, et al. <year>2000</year>
<article-title>Physical activity levels in patients on hemodialysis and healthy sedentary controls</article-title>. <source xml:lang="en">Kidney Int.</source>
<volume>57</volume>:<fpage>2564</fpage>–<lpage>2570</lpage>.<pub-id pub-id-type="pmid">10844626</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0042">
                <mixed-citation publication-type="journal" id="phy213825-cit-0042"><string-name><surname>Jy</surname>, <given-names>W.</given-names></string-name>, <string-name><given-names>L. L.</given-names><surname>Horstman</surname></string-name>, <string-name><given-names>J. J.</given-names><surname>Jimenez</surname></string-name>, <string-name><given-names>Y. S.</given-names><surname>Ahn</surname></string-name>, <string-name><given-names>E.</given-names><surname>Biró</surname></string-name>, <string-name><given-names>R.</given-names><surname>Nieuwland</surname></string-name>, et al. <year>2004</year>
<article-title>Measuring circulating cell‐derived microparticles</article-title>. <source xml:lang="en">J. Thromb. Haemost.</source>
<volume>2</volume>:<fpage>1842</fpage>–<lpage>1851</lpage>.<pub-id pub-id-type="pmid">15456497</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0043">
                <mixed-citation publication-type="journal" id="phy213825-cit-0043"><string-name><surname>Kaysen</surname>, <given-names>G. A.</given-names></string-name><year>2014</year><article-title>Progressive inflammation and wasting in patients with ESRD</article-title>. <source xml:lang="en">Clin. J. Am. Soc. Nephrol.</source><volume>9</volume>:<fpage>225</fpage>–<lpage>226</lpage>.<pub-id pub-id-type="pmid">24458072</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0044">
                <mixed-citation publication-type="journal" id="phy213825-cit-0044"><string-name><surname>Kim</surname>, <given-names>J. S.</given-names></string-name>, <string-name><given-names>B.</given-names><surname>Kim</surname></string-name>, <string-name><given-names>H.</given-names><surname>Lee</surname></string-name>, <string-name><given-names>S.</given-names><surname>Thakkar</surname></string-name>, <string-name><given-names>D. M.</given-names><surname>Babbitt</surname></string-name>, <string-name><given-names>S.</given-names><surname>Eguchi</surname></string-name>, et al. <year>2015</year>
<article-title>Shear stress‐induced mitochondrial biogenesis decreases the release of microparticles from endothelial cells</article-title>. <source xml:lang="en">Am. J. Physiol. Heart Circ. Physiol.</source>
<volume>309</volume>:<fpage>H425</fpage>–<lpage>H433</lpage>.<pub-id pub-id-type="pmid">26024684</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0045">
                <mixed-citation publication-type="journal" id="phy213825-cit-0045"><string-name><surname>Kurts</surname>, <given-names>C.</given-names></string-name>, <string-name><given-names>U.</given-names><surname>Panzer</surname></string-name>, <string-name><given-names>H. J.</given-names><surname>Anders</surname></string-name>, and <string-name><given-names>A. J.</given-names><surname>Rees</surname></string-name>. <year>2013</year><article-title>The immune system and kidney disease: basic concepts and clinical implications</article-title>. <source xml:lang="en">Nat. Rev. Nephrol.</source><volume>13</volume>:<fpage>738</fpage>–<lpage>753</lpage>.</mixed-citation>
              </ref>
              <ref id="phy213825-bib-0046">
                <mixed-citation publication-type="journal" id="phy213825-cit-0046"><string-name><surname>La Favor</surname>, <given-names>J. D.</given-names></string-name>, <string-name><given-names>G. S.</given-names><surname>Dubis</surname></string-name>, <string-name><given-names>H.</given-names><surname>Yan</surname></string-name>, <string-name><given-names>J. D.</given-names><surname>White</surname></string-name>, <string-name><given-names>M. A.</given-names><surname>Nelson</surname></string-name>, <string-name><given-names>E. J.</given-names><surname>Anderson</surname></string-name>, et al. <year>2016</year>
<article-title>Microvascular endothelial dysfunction in sedentary, obese humans is mediated by NADPH oxidase: influence of exercise training</article-title>. <source xml:lang="en">Arterioscler. Thromb. Vasc. Biol.</source>
<volume>36</volume>:<fpage>2412</fpage>–<lpage>2420</lpage>.<pub-id pub-id-type="pmid">27765769</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0047">
                <mixed-citation publication-type="journal" id="phy213825-cit-0047"><string-name><surname>Lansford</surname>, <given-names>K. A.</given-names></string-name>, <string-name><given-names>D. D.</given-names><surname>Shill</surname></string-name>, <string-name><given-names>A. B.</given-names><surname>Dicks</surname></string-name>, <string-name><given-names>M. P.</given-names><surname>Marshburn</surname></string-name>, <string-name><given-names>W. M.</given-names><surname>Southern</surname></string-name>, and <string-name><given-names>N. T.</given-names><surname>Jenkins</surname></string-name>. <year>2016</year><article-title>Effect of acute exercise on circulating angiogenic cell and microparticle populations</article-title>. <source xml:lang="en">Exp. Physiol.</source><volume>101</volume>:<fpage>155</fpage>–<lpage>167</lpage>.<pub-id pub-id-type="pmid">26487283</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0048">
                <mixed-citation publication-type="journal" id="phy213825-cit-0048"><string-name><surname>Latham</surname>, <given-names>S. L.</given-names></string-name>, <string-name><given-names>N.</given-names><surname>Tiberti</surname></string-name>, <string-name><given-names>N.</given-names><surname>Gokoolparsadh</surname></string-name>, <string-name><given-names>K.</given-names><surname>Holdaway</surname></string-name>, <string-name><given-names>P. O.</given-names><surname>Couraud</surname></string-name>, <string-name><given-names>G. E.</given-names><surname>Grau</surname></string-name>, et al. <year>2015</year>
<article-title>Immuno‐analysis of microparticles: probing at the limits of detection</article-title>. <source xml:lang="en">Sci. Rep.</source>
<volume>5</volume>:<fpage>16314</fpage>.<pub-id pub-id-type="pmid">26553743</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0049">
                <mixed-citation publication-type="journal" id="phy213825-cit-0049"><string-name><surname>Maas</surname>, <given-names>S. L. N.</given-names></string-name>, <string-name><given-names>J.</given-names><surname>de Vrij</surname></string-name>, <string-name><given-names>E. J.</given-names><surname>van der Vlist</surname></string-name>, <string-name><given-names>B.</given-names><surname>Geragousian</surname></string-name>, <string-name><given-names>L.</given-names><surname>van Bloois</surname></string-name>, <string-name><given-names>E.</given-names><surname>Mastrobattista</surname></string-name>, et al. <year>2015</year>
<article-title>Possibilities and limitations of current technologies for quantification of biological extracellular vesicles and synthetic mimics</article-title>. <source xml:lang="en">J. Contr. Rel.</source>
<volume>200</volume>:<fpage>87</fpage>–<lpage>96</lpage>.</mixed-citation>
              </ref>
              <ref id="phy213825-bib-0050">
                <mixed-citation publication-type="journal" id="phy213825-cit-0050"><string-name><surname>Morel</surname>, <given-names>O.</given-names></string-name>, <string-name><given-names>L.</given-names><surname>Jesel</surname></string-name>, <string-name><given-names>J. M.</given-names><surname>Freyssinet</surname></string-name>, and <string-name><given-names>F.</given-names><surname>Toti</surname></string-name>. <year>2011</year><article-title>Cellular mechanisms underlying the formation of circulating microparticles</article-title>. <source xml:lang="en">Arterioscler. Thromb. Vasc. Biol.</source><volume>31</volume>:<fpage>15</fpage>–<lpage>26</lpage>.<pub-id pub-id-type="pmid">21160064</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0051">
                <mixed-citation publication-type="journal" id="phy213825-cit-0051"><string-name><surname>Nielsen</surname>, <given-names>M. H.</given-names></string-name>, <string-name><given-names>H.</given-names><surname>Beck‐Nielsen</surname></string-name>, <string-name><given-names>M. N.</given-names><surname>Andersen</surname></string-name>, and <string-name><given-names>A.</given-names><surname>Handberg</surname></string-name>. <year>2014</year><article-title>A flow cytometric method for characterisation of circulating cell‐derived microparticles in plasma</article-title>. <source xml:lang="en">J. Extracell. Vesicles</source><volume>3</volume>:<fpage>20795</fpage>.</mixed-citation>
              </ref>
              <ref id="phy213825-bib-0052">
                <mixed-citation publication-type="journal" id="phy213825-cit-0052"><string-name><surname>Nilsson</surname>, <given-names>B.</given-names></string-name>, <string-name><given-names>K.</given-names><surname>Nilsson Ekdahl</surname></string-name>, <string-name><given-names>T. E.</given-names><surname>Mollnes</surname></string-name>, and <string-name><given-names>J. D.</given-names><surname>Lambris</surname></string-name>. <year>2007</year><article-title>The role of complement in biomaterial‐induced inflammation</article-title>. <source xml:lang="en">Mol. Immunol.</source><volume>44</volume>:<fpage>82</fpage>–<lpage>94</lpage>.<pub-id pub-id-type="pmid">16905192</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0053">
                <mixed-citation publication-type="journal" id="phy213825-cit-0053"><string-name><surname>O'Hare</surname>, <given-names>A. M.</given-names></string-name>, <string-name><given-names>K.</given-names><surname>Tawney</surname></string-name>, <string-name><given-names>P.</given-names><surname>Bacchetti</surname></string-name>, and <string-name><given-names>K. L.</given-names><surname>Johansen</surname></string-name>. <year>2003</year><article-title>Decreased survival among sedentary patients undergoing dialysis: results from the dialysis morbidity and mortality study wave 2</article-title>. <source xml:lang="en">Am. J. Kidney Dis.</source><volume>41</volume>:<fpage>447</fpage>–<lpage>454</lpage>.<pub-id pub-id-type="pmid">12552509</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0054">
                <mixed-citation publication-type="journal" id="phy213825-cit-0054"><string-name><surname>Owens</surname>, <given-names>A. P.</given-names></string-name>, <string-name><given-names>N.</given-names>, <surname>Mackman</surname></string-name>. <year>2011</year><article-title>Microparticles in hemostasis and thrombosis</article-title>. <source xml:lang="en">Circ. Res.</source><volume>108</volume>:<fpage>1284</fpage>–<lpage>1297</lpage>.<pub-id pub-id-type="pmid">21566224</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0055">
                <mixed-citation publication-type="journal" id="phy213825-cit-0055"><string-name><surname>Pitha</surname>, <given-names>J.</given-names></string-name>, <string-name><given-names>I.</given-names><surname>Králova Lesná</surname></string-name>, <string-name><given-names>P.</given-names><surname>Stávek</surname></string-name>, <string-name><given-names>A.</given-names><surname>Mahrová</surname></string-name>, <string-name><given-names>J.</given-names><surname>Racek</surname></string-name>, <string-name><given-names>A.</given-names><surname>Sekerková</surname></string-name>, et al. <year>2015</year>
<article-title>Effect of exercise on markers of vascular health in renal transplant recipients</article-title>. <source xml:lang="en">Physiol. Res.</source>
<volume>64</volume>:<fpage>945</fpage>–<lpage>949</lpage>.<pub-id pub-id-type="pmid">26447524</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0056">
                <mixed-citation publication-type="journal" id="phy213825-cit-0056"><string-name><surname>Pospichalova</surname>, <given-names>V.</given-names></string-name>, <string-name><given-names>J.</given-names><surname>Svoboda</surname></string-name>, <string-name><given-names>Z.</given-names><surname>Dave</surname></string-name>, <string-name><given-names>A.</given-names><surname>Kotrbova</surname></string-name>, <string-name><given-names>K.</given-names><surname>Kaiser</surname></string-name>, <string-name><given-names>D.</given-names><surname>Klemova</surname></string-name>, et al. <year>2015</year>
<article-title>Simplified protocol for flow cytometry analysis of fluorescently labelled exosomes and microvesicles using dedicated flow cytometer</article-title>. <source xml:lang="en">J. Extracell. Ves.</source>
<volume>4</volume>:<fpage>1</fpage>.</mixed-citation>
              </ref>
              <ref id="phy213825-bib-0057">
                <mixed-citation publication-type="journal" id="phy213825-cit-0057"><string-name><surname>Puddu</surname>, <given-names>P.</given-names></string-name>, <string-name><given-names>G. M.</given-names><surname>Puddu</surname></string-name>, <string-name><given-names>E.</given-names><surname>Cravero</surname></string-name>, <string-name><given-names>S.</given-names><surname>Muscari</surname></string-name>, and <string-name><given-names>A.</given-names><surname>Muscari</surname></string-name>. <year>2010</year><article-title>The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases</article-title>. <source xml:lang="en">Can. J. Cardiol.</source><volume>26</volume>:<fpage>e140</fpage>–<lpage>e145</lpage>.</mixed-citation>
              </ref>
              <ref id="phy213825-bib-0058">
                <mixed-citation publication-type="journal" id="phy213825-cit-0058"><string-name><surname>Ramirez</surname>, <given-names>R.</given-names></string-name>, <string-name><given-names>J.</given-names><surname>Carracedo</surname></string-name>, <string-name><given-names>A.</given-names><surname>Merino</surname></string-name>, <string-name><given-names>S.</given-names><surname>Nogueras</surname></string-name>, <string-name><given-names>M. A.</given-names><surname>Alvarez‐Lara</surname></string-name>, <string-name><given-names>M.</given-names><surname>Rodríguez</surname></string-name>, et al. <year>2007</year>
<article-title>Microinflammation induces endothelial damage in hemodialysis patients: the role of convective transport</article-title>. <source xml:lang="en">Kidney Int.</source>
<volume>72</volume>:<fpage>108</fpage>–<lpage>113</lpage>.<pub-id pub-id-type="pmid">17429343</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0059">
                <mixed-citation publication-type="journal" id="phy213825-cit-0059"><string-name><surname>Rao</surname>, <given-names>L. V. M.</given-names></string-name>, <string-name><given-names>H.</given-names><surname>Kothari</surname></string-name>, and <string-name><given-names>U. R.</given-names><surname>Pendurthi</surname></string-name>. <year>2012</year><article-title>Tissue factor: mechanisms of decryption</article-title>. <source xml:lang="en">Front Biosci.</source><volume>4</volume>:<fpage>1513</fpage>–<lpage>1527</lpage>.</mixed-citation>
              </ref>
              <ref id="phy213825-bib-0060">
                <mixed-citation publication-type="journal" id="phy213825-cit-0060"><string-name><surname>Robert</surname>, <given-names>S.</given-names></string-name>, <string-name><given-names>P.</given-names><surname>Poncelet</surname></string-name>, <string-name><given-names>R.</given-names><surname>Lacroix</surname></string-name>, <string-name><given-names>L.</given-names><surname>Arnaud</surname></string-name>, <string-name><given-names>L.</given-names><surname>Giraudo</surname></string-name>, <string-name><given-names>A.</given-names><surname>Hauchard</surname></string-name>, et al. <year>2008</year>
<article-title>Standardization of platelet‐derived microparticle counting using calibrated beads and a cytomics FC500 routine flow cytometer: a first step towards multicenter studies?</article-title>
<source xml:lang="en">J. Thromb. Haemost.</source>
<volume>7</volume>:<fpage>190</fpage>–<lpage>197</lpage>.<pub-id pub-id-type="pmid">18983485</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0061">
                <mixed-citation publication-type="journal" id="phy213825-cit-0061"><string-name><surname>Robinson</surname>, <given-names>A. T.</given-names></string-name>, <string-name><given-names>I. S.</given-names><surname>Fancher</surname></string-name>, <string-name><given-names>V.</given-names><surname>Sudhahar</surname></string-name>, <string-name><given-names>J. T.</given-names><surname>Bian</surname></string-name>, <string-name><given-names>M. D.</given-names><surname>Cook</surname></string-name>, <string-name><given-names>A. M.</given-names><surname>Mahmoud</surname></string-name>, et al. <year>2017</year>
<article-title>Short‐term regular aerobic exercise reduces oxidative stress produced by acute in the adipose microvasculature</article-title>. <source xml:lang="en">Am. J. Physiol. Heart Circ. Physiol.</source>
<volume>312</volume>:<fpage>H896</fpage>–<lpage>H906</lpage>.<pub-id pub-id-type="pmid">28235790</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0062">
                <mixed-citation publication-type="journal" id="phy213825-cit-0062"><string-name><surname>Scholz</surname>, <given-names>T.</given-names></string-name>, <string-name><given-names>U.</given-names><surname>Temmler</surname></string-name>, <string-name><given-names>S.</given-names><surname>Krause</surname></string-name>, <string-name><given-names>S.</given-names><surname>Heptinstall</surname></string-name>, and <string-name><given-names>W.</given-names><surname>Losche</surname></string-name>. <year>2002</year><article-title>Transfer of tissue factor from platelets to monocytes: role of platelet‐derived microvesicles and CD62P</article-title>. <source xml:lang="en">Thromb. Haemost.</source><volume>88</volume>:<fpage>1033</fpage>–<lpage>1038</lpage>.<pub-id pub-id-type="pmid">12529756</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0063">
                <mixed-citation publication-type="journal" id="phy213825-cit-0063"><string-name><surname>Shoji</surname>, <given-names>T.</given-names></string-name>, <string-name><given-names>Y.</given-names><surname>Tsubakihara</surname></string-name>, <string-name><given-names>M.</given-names><surname>Fujii</surname></string-name>, and <string-name><given-names>E.</given-names><surname>Imai</surname></string-name>. <year>2004</year><article-title>Hemodialysis‐associated hypotension as an independent risk factor for two‐year mortality in hemodialysis patients</article-title>. <source xml:lang="en">Kidney Int.</source><volume>66</volume>:<fpage>1212</fpage>–<lpage>1220</lpage>.<pub-id pub-id-type="pmid">15327420</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0064">
                <mixed-citation publication-type="journal" id="phy213825-cit-0064"><string-name><surname>Spronk</surname>, <given-names>H. M.</given-names></string-name>, <string-name><given-names>H.</given-names><surname>ten Cate</surname></string-name>, and <string-name><given-names>P. E.</given-names><surname>van der Meijden</surname></string-name>. <year>2014</year><article-title>Differential roles of tissue factor and phosphatidylserine in activation of coagulation</article-title>. <source xml:lang="en">Thromb. Res.</source><volume>133</volume>:<fpage>S54</fpage>–<lpage>S56</lpage>.<pub-id pub-id-type="pmid">24759145</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0065">
                <mixed-citation publication-type="journal" id="phy213825-cit-0065"><string-name><surname>Stenvinkel</surname>, <given-names>P.</given-names></string-name><year>2010</year><article-title>Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease</article-title>. <source xml:lang="en">J. Intern. Med.</source><volume>268</volume>:<fpage>456</fpage>–<lpage>467</lpage>.<pub-id pub-id-type="pmid">20809922</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0066">
                <mixed-citation publication-type="journal" id="phy213825-cit-0066"><string-name><surname>Trappenburg</surname>, <given-names>M. C.</given-names></string-name>, <string-name><given-names>M.</given-names><surname>van Schilfgaarde</surname></string-name>, <string-name><given-names>F. C.</given-names><surname>Frerichs</surname></string-name>, <string-name><given-names>H. M.</given-names><surname>Spronk</surname></string-name>, <string-name><given-names>H.</given-names><surname>ten Cate</surname></string-name>, <string-name><given-names>C. W.</given-names><surname>de Fijter</surname></string-name>, et al. <year>2012</year>
<article-title>Chronic renal failure is accompanied by endothelial activation and a large increase in microparticle numbers with reduced procoagulant capacity</article-title>. <source xml:lang="en">Nephrol. Dial. Transplant.</source>
<volume>27</volume>:<fpage>1446</fpage>–<lpage>1453</lpage>.<pub-id pub-id-type="pmid">21873622</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0067">
                <mixed-citation publication-type="journal" id="phy213825-cit-0067"><string-name><surname>Tushuizen</surname>, <given-names>M. E.</given-names></string-name>, <string-name><given-names>M.</given-names><surname>Diamant</surname></string-name>, <string-name><given-names>A.</given-names><surname>Sturk</surname></string-name>, and <string-name><given-names>R.</given-names><surname>Nieuwland</surname></string-name>. <year>2011</year><article-title>Cell‐derived microparticles in the pathogenesis of cardiovascular disease: friend or foe<italic>?</italic>
</article-title><source xml:lang="en">Arterioscler. Thromb. Vasc. Biol.</source><volume>31</volume>:<fpage>4</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">21160062</pub-id></mixed-citation>
              </ref>
              <ref id="phy213825-bib-0068">
                <mixed-citation publication-type="journal" id="phy213825-cit-0068"><string-name><surname>Wahl</surname>, <given-names>P.</given-names></string-name>, <string-name><given-names>F.</given-names><surname>Jansen</surname></string-name>, <string-name><given-names>S.</given-names><surname>Achtzehn</surname></string-name>, <string-name><given-names>T.</given-names><surname>Schmitz</surname></string-name>, <string-name><given-names>W.</given-names><surname>Bloch</surname></string-name>, <string-name><given-names>J.</given-names><surname>Mester</surname></string-name>, et al. <year>2014</year>
<article-title>Effects of high intensity training and high volume training on endothelial microparticles and angiogenic growth factors</article-title>. <source xml:lang="en">PLoS ONE</source>
<volume>9</volume>:<fpage>e96024</fpage>.<pub-id pub-id-type="pmid">24770423</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
